User:Liao Ti-Hui/沙盒

下表是人類分化群（Cluster of differentiation, CD）分子的列表。 * = group; ** = not listed on hcdm

CD1~50

CD1系列

CD1系列是分布在抗原呈遞細胞（APC，包含樹突細胞、單核球、某些胸腺細胞等）表面的醣蛋白，由1號染色體上的基因調控。它們與MHC I類似，可以呈現抗原的脂質分子^[1]。CD1系列分為兩群，第一群（A、B、C）大致只分布於抗原呈遞細胞，第二群（D）則分布較為普遍。^[2]

CD1a: CD1a（英语：CD1A）是T細胞表面的醣蛋白，屬於CD1第一群，由CD1A基因調控。它與自體或外來的脂質或糖脂結合，將這些分子呈現給NKT細胞（CD161（英语：KLRB1）膜上的T細胞受體。
CD1b: CD1b（英语：CD1b）是T細胞表面的醣蛋白，屬於CD1第一群，由CD1B基因調控，主要分布於Tαβ細胞表面^[3]。在CD1群中，它與微生物抗原親和力可能最強。; CD1b常表現於胸腺細胞與白血病的T細胞，與多發性硬化症可能有關。
CD1c: CD1c（英语：CD1c）是T細胞表面的醣蛋白，屬於CD1第一群，由CD1C基因調控。
CD1d: CD1D（英语：CD1d）是T細胞表面的醣蛋白，屬於CD1第二群，由CD1D基因調控，又稱R3G1。它與自體或外來的脂質結合，將這些分子呈現給NKT細胞膜上的T細胞受體。^[4]
CD1e: CD1E（英语：CD1e）是T細胞表面的醣蛋白，由CD1E基因調控。作用機轉尚未明朗。

CD2

CD2: CD2是胸腺細胞、T細胞及NK細胞表面的第一型跨膜蛋白，為CD58及CD59的配位基，參與訊號傳導與細胞黏附。; CD2在T細胞淋巴瘤與T細胞急性淋巴母細胞白血病（英语：Adult T-cell leukemia/lymphoma）（T-ALL）中常會表現。

CD3系列

CD3（英语：CD3 (immunology)）是T細胞受體的輔受體（英语：Co-receptor）蛋白，為活化T細胞之必需。包含四種胜肽鏈：

CD3g（CD3γ）: CD3g（英语：CD3G）是T細胞受體複合體八條胜肽鏈之一。
CD3d（CD3δ）: CD3d（英语：CD3D）是T細胞受體複合體八條胜肽鏈之一，會與CD8a（英语：CD8A）互動。
CD3e（CD3ε）: CD3e（英语：CD3E）是T細胞受體複合體八條胜肽鏈中的兩條，由11號染色體的CD3E基因規範。

T細胞受體複合體中的最後兩條胜肽鏈CD3ζ（英语：T-cell surface glycoprotein CD3 zeta chain）已被編號為CD247。^[5]

CD4~7

CD4: CD4是T細胞受體MHC II（英语：MHC class II）的輔受體醣蛋白，出現在輔助T細胞、單核球、巨噬細胞和樹突細胞表面，屬於免疫球蛋白超家族（英语：Immunoglobulin superfamily）。; HIV利用CD4鑽進細胞，CD4也與白癜風（Vitiligo）、第一型糖尿病等自體免疫疾病相關。^[6]
CD5: CD5（英语：CD5 (protein)）是T細胞、胸腺細胞與B1a細胞表面的第一型跨膜蛋白^[7]，由11號染色體規範，為CD72（英语：CD72）的配位基^[8]，參與免疫細胞活化與黏附。; CD5表現於B細胞慢性淋巴細胞白血病（B-CLL）、被套細胞淋巴瘤（ML）及T細胞淋巴瘤。^[9]
CD6: CD6是胸腺細胞黏附上皮細胞用的蛋白質，也出現在成熟T細胞表面，會與CD166（英语：CD166）結合。; CD6與多發性硬化症有關。^[10]^[11]
CD7: CD7是胸腺細胞、T細胞、單核球、NK細胞及造血幹細胞表面的第一型跨膜蛋白。; CD7表現於蕈狀肉芽腫（英语：Mycosis fungoides）、T細胞急性淋巴性白血病（T-ALL）以及一小部分的急性骨髓性白血病（AML）病人身上。^[12]

CD8系列

CD8: CD8是T細胞受體MHC I的輔受體醣蛋白，屬於免疫球蛋白超家族（英语：Immunoglobulin superfamily），大多出現在胞毒T細胞表面，但在NK細胞、胸腺細胞與部分的樹突細胞上也能發現。CD8包含兩種同功型（英语：isoform），α與β。; CD8表現於T淋巴母細胞白血病（英语：T-lymphoblastic leukemia/lymphoma）與蕈狀肉芽腫（英语：Mycosis fungoides）病人身上。^[9]; 在HIV感染時，CD8⁺胞毒T細胞會辨別並殺死感染的CD4⁺輔助T細胞。; 在B型肝炎感染時，CD8⁺胞毒T細胞會製造抗病毒的細胞激素（cytokines）殺死感染的肝臟細胞，造成肝臟損傷。
CD8α: CD8α醣蛋白由CD8A（英语：CD8A）基因規範，它的IgV狀結構能與MHC I的α3部件結合^[13]，並與CD3d（英语：CD3D）^[14]、HLA-A^[15]^[16]及HLA-G（英语：HLA-G）^[15]^[17]互動。
CD8β: CD8β是T細胞表面的醣蛋白。

CD9~10

CD9: CD9標示四跨膜蛋白（Tetraspanin），它是一種醣蛋白，屬於第四型跨膜蛋白，參與細胞黏附、移動、膜融合與傳訊。^[18]^[19]^[20]^[21]^[22]^[23]^[24]; CD9表現於pre-B、嗜酸性球、嗜鹼性球及血小板^[25]，並與金黃色葡萄球菌的黏附^[26]以及癌症轉移有關。^[27]^[28]^[29]^[30]^[31]
CD10: CD10標示腦啡肽酶，出現於部分嗜中性球、腎細胞、前驅T細胞（T-cell precursor）、上皮細胞及在生發中心前的B細胞^[32]。; 腦啡肽酶是一種鋅金屬蛋白酶，屬於第二型跨膜蛋白，能結合胺基酸疏水端。; CD10表現於急性淋巴性白血病（ALL）與濾泡淋巴瘤（英语：Follicular lymphoma）（FL）。

CD11系列

CD11系列標示四種整聯素α（Integrin alpha）。

CD11A: CD11A標示整聯素αL（英语：Integrin alpha L）（ITGAL），它是LFA-1的α單元，藉由與ICAM-1（英语：ICAM-1）互動，讓淋巴球黏附其他細胞。^[33]
CD11B: CD11B標示整聯素αM（英语：Integrin alpha M）（ITGAM），它是Mac-1（英语：Macrophage-1 antigen）的α單元，與CD18組成補體受體3（CR3），表現於顆粒球（特別是嗜中性球）、NK細胞與單核球表面，用於辨認、結合抗原，並引起吞噬作用。
CD11C: CD11C標示整聯素αX（英语：Integrin alpha X）（ITGAX），它是第一型跨膜蛋白，與CD18組成補體受體4（CR4），表現於單核球、巨噬細胞、嗜中性球、B細胞與樹突細胞表面，用於引發呼吸爆炸（英语：Respiratory burst）。; CD11C表現於髮細胞白血病（英语：Hairy cell leukemia）（HCL）、急性骨髓性白血病（AML）與部分B細胞慢性淋巴細胞白血病（B-CLL）。
CD11D: CD11D標示整聯素αD（英语：Integrin alpha D）（ITGAD），它與CD18組成ICAM3（英语：ICAM3）與VCAM-1。; CD11D表現於吞噬衰老紅血球與動脈粥狀硬化清理脂蛋白的場合中。

CD13~15

CD13: CD13標示丙氨酸氨肽酶（AAP, AP-N）,它是一種鋅金屬蛋白，在骨髓單核球（Myelomonocyte）早期分化時出現，因此CD13經常在急性骨髓性白血病（AML）出現，偶爾表現於淋巴瘤與淋巴性白血病。^[34]
CD14: CD14是結合脂多醣（LPS）的細胞蛋白，作用於先天性免疫。^[35]^[36]
CD15: CD15標示Sialyl-Lewis X（英语：Sialyl-Lewis X）（sLeX, SSEA-1），它是一種四醣（而非蛋白質），出現於嗜中性球，中介吞噬作用與免疫趨化作用^[37]。; CD15表現於霍奇金淋巴瘤、B細胞慢性淋巴細胞白血病（B-CLL）及急性骨髓性白血病（AML），在胚胎黏附與移動、癌症轉移等方面也有功能。

CD16*	FcγRIII, a low-affinity Fc receptor for IgG. Found on NK cells, macrophages, and neutrophils.
CD16a	Low affinity immunoglobulin gamma Fc region receptor III-A encoded by the FCGR3A gene. Mutations in the gene associated with immunodeficiency, particularly severe Epstein Barr virus and HPV infections.
CD16b	Low affinity immunoglobulin gamma Fc region receptor III-B encoded by the FCGR3B gene. Expressed by neutrophils and stimulated eosinophils
CD17	possible role in phagocytosis. Bacteria binding.
CD18	Integrin Beta 2 chain (ITGB2). Adhesion and signaling in the hematopoietic system.
CD19	B-lymphocyte surface antigen B4, component of the B-cell co-receptor; highly represented in B-cell malignancies, CD19 is the target of several CAR-T and mAb cancer drugs in development e.g. Juno JCAR015, Kite KTE-C19 CAR, Novartis CTL019, Morphosys MOR208, Macrogenics MGD011, Affimed AFM11
CD20	a type III transmembrane protein found on B cells that forms a calcium channel in the cell membrane allowing for the influx of calcium required for cell activation; expressed in B-cell lymphomas, hairy cell leukemia, and B-cell chronic lymphocytic leukemia. Important for therapy of those diseases, as antibodies against CD20 exist: e.g. Rituximab and Ofatumumab, with several more in development. Similarly, anti-CD20 monoclonal antibody Ocrelizumab is in trials for multiple sclerosis.
CD21	CR2, a type I transmembrane protein found in the cytoplasm of pre-B cells and on the surface of mature B cells, follicular dendritic cells, pharyngeal and cervical epithelial cells, some thymocytes, and some T cells that plays a role in signal transduction; expressed in hairy cell leukemia, B-cell lymphoma, and some T-cell acute lymphocytic leukemias. Receptor for complement (C3d) and Epstein–Barr virus (EBV).
CD22	a sugar binding transmembrane protein that specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. It is a member of the immunoglobulin superfamily and the SIGLEC family. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signalling. Like CD19, CD22 is a cell surface marker for lymphocytes that is present on most B cell malignancies, including acute lymphoblastic leukemia and various subtypes of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma. CD22 expression has been shown to be maintained in acute lymphoblastic leukemia that has lost CD19, making anti-CD22 a potential combination or follow on therapy for anti-CD19 therapy. Anti-CD22 monoclonal antibodies have been developed, without much success yet; currently Juno Therapeutics has an anti-CD22 CAR-T in development.
CD23	a type II transmembrane protein found on mature B cells, monocytes, activated macrophages, eosinophils, platelets, and dendritic cells that enhances capture and processing of antigen complexed with IgE.
CD24	a glycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. This gene encodes a sialoglycoprotein that is expressed on mature granulocytes and in many B cells. The encoded protein is anchored via a glycosyl phosphatidylinositol (GPI) link to the cell surface. Is also known as Heat Stable Antigen (HSA).
CD25	a type I transmembrane protein present on activated T cells, activated B cells, some thymocytes, myeloid precursors, and oligodendrocytes that associates with CD122 to form a heterodimer that can act as a high-affinity receptor for IL-2; expressed in most B-cell neoplasms, some acute nonlymphocytic leukemias, and neuroblastomas.
CD26	Membrane-bound protease. T-cell costimulatory molecule. Cell adhesion molecule
CD27	TNF-receptor (Tumor necrosis factor receptor superfamily member 7). Present on the surface of resting memory B cells. Binds to ligand CD70. Celldex has an agonist anti-CD27 mAb, CDX-1127, in early stage trials, which activates T-cells by substituting for CD70 and may have anti-tumour effects. Human B and T cell lymphomas often express CD27 at high levels.
CD28	costimulatory receptor present on all T-cells. It functions by binding one of two possible costimulatory ligands, CD80 (B7.1) or CD86 (B7.2), thus eliciting a costimulatory effect on the T-cell
CD29	AKA integrin beta-1 - a cell adhesion molecule.
CD30	a type I transmembrane protein present on activated T and B cells that may play a role in cell activation and/or differentiation; expressed in Hodgkin disease, some T-cell lymphomas, and anaplastic large cell lymphomas.
CD31	PECAM-1, a cell adhesion molecule on platelets and endothelial cells
CD32A**	FcγRII-a, a receptor for the Fc (constant) region of immunoglobulin G (IgG). Of the related pair FCGR2A and FCGR2B (CD32B), the 'A' type is considered the activating isoform.
CD32B**	FcγRII-b, a receptor for the Fc (constant) region of immunoglobulin G (IgG). Of the related pair FCGR2A (CD32A) and FCGR2B, the 'B' type is considered the inhibitory isoform. Ligation of CD32B on B cells downregulates antibody production and may, in some circumstances, promote apoptosis. Co-ligation of CD32B on dendritic cells inhibits maturation and blocks cell activation.
CD33	a marker of unknown function found on immature myeloid cells, including acute myeloid leukemia blasts and mature monocytes. Anti-CD33 monoclonal antibodies are extensively used for the diagnosis of all types of AMLs.
CD34	stem cell marker, adhesion, found on hematopoietic precursors (found in high concentrations in umbilical cord blood), capillary endothelium, and embryonic fibroblasts
CD35	Complement receptor 1 (C3b/C4b receptor)
CD36	Platelet glycoprotein IV or IIIb (GP IV / GP IIIb)
CD37	A leucocyte restricted tetraspanin expressed primarily in B cells, but also found on T cells, Monocytes and Granulocytes.
CD38	involved in ecto-ADP-ribosyl cyclase and cell activation on many hematopoietic, plasma, and B & T activated cells; marker increases with HIV seroconversion, coexpression with CD8 associated with progression (indicates persistent viral stimulation). Some antibodies targeting CD38 are being tested in multiple myeloma and non-Hodgkin's lymphoma e.g. Daratumumab or Celgene's MOR202.
CD39	Also known as Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1). Hydrolyzes nucleotide substrates at extremely high turnover rates, converting ATP directly into AMP without releasing ADP. Forms oligomers that are essential for its enzymatic activity.
CD40	A costimulatory protein found on antigen presenting cells. CD40 combines with its ligand CD154 (CD40L) on T cells to induce antibody isotype switching in B cells. Under investigation as an antibody target for solid tumor (e.g. Roche RG7876).
CD41	Integrin subunit αIIb; Gene ITGA2B. Glycoprotein IIb (GPIIb): Component of the integrin αIIbβ3 (GPIIb-IIIa) fibrinogen receptor; major role is in platelet aggregation.^[38] Mutations in ITGA2B can be causative for Glanzmann thrombasthenia.
CD42*	the platelet Glycoprotein Ib/V/IX complex(GPIb/V/IX). Expressed on platelets and is a late, specific marker of megakaryocyte differentiation. The Glycoprotein Ib/V/IX complex is essential for normal haemostasis; deficiency results in Bernard-Soulier Syndrome, a syndrome of thrombocytopenia and giant platelets.
CD42a	Platelet glycoprotein IX (GPIX) encoded by the GP9 gene.
CD42b	Platelet glycoprotein Ib alpha chain encoded by the GP1BA gene.
CD42c	Platelet glycoprotein Ib beta chain encoded by the GP1BB gene.
CD42d	Platelet glycoprotein V encoded by the GP5 gene.
CD43	CD43 is a sialomucin.
CD44	A family of matrix adhesion molecules formed by alternative mRNA splicing, that adhere to hyaluronate, collagen, laminin, and fibronectin. Helps maintain polarization of epithelial cells. Found on bone marrow stromal cells and many other cells.
CD45	leucocyte common antigen, a type I transmembrane protein present on all hemopoietic cells except erythrocytes that assists in cell activation; expressed in lymphomas, B-cell chronic lymphocytic leukemia, hairy cell leukemia, and acute nonlymphocytic leukemia.
CD46	Inhibitory complement receptor which is ubiquitously expressed on human cells. Binding site for viral H (Hemagglutinin) protein.
CD47	Membrane protein, which is involved in the increase in intracellular calcium concentration that occurs upon cell adhesion to extracellular matrix. Binds to TSP-1 and SIRPa (CD172A). Tumor cells can evade macrophage phagocytosis through CD47 expression. An experimental drug from Trillium, SIRPαFc, targets CD47 thus allowing macrophages to destroy tumor cells in acute myeloid leukemia. In 2016, Celgene via Inhibrx, Forty Seven and several other biotech companies are also trialling anti-CD47 molecules to treat various cancers and other indications.
CD48	CD48 is a human protein encoded by the CD48 gene. It is a universal cell membrane molecule present on all leukocytes.
CD49a	Integrin alpha 1 subunit.
CD49b	Very late antigen (VLA) alpha 2 chain; found on platelets and activated B and T cells.
CD49c	Very late antigen (VLA) alpha 3 chain; found on nonhematopoietic bone marrow cells. Receptor for collagen, laminin, fibronectin, and thrombospondin.
CD49d	Integrin alpha 4 subunit. Unlike other integrin alpha chains, alpha 4 neither contains an I-domain, nor undergoes disulfide-linked cleavage.
CD49e	Integrin alpha 5 subunit. Alpha chain 5 undergoes post-translational cleavage in the extracellular domain to yield disulfide-linked light and heavy chains that join with beta 1 to form a fibronectin receptor.
CD49f	Integrin alpha 6 subunit.
CD50	Intercellular adhesion molecule 3 encoded by the ICAM3 gene.
CD51	CD51 is a type I integral membrane glycoprotein, known as vitronectin receptor α chain, or integrin αV. It forms heterodimer with integrin β1 (CD29), β3 (CD61), β5, β6, or β8. CD51 contains two disulfide-linked subunits of 125 kD and 24 kD, and is expressed on endothelial cells, fibroblasts, macrophages, platelets, osteoclasts, neuroblastoma, melanoma, and hepatoma cells.^[39]
CD52	CAMPATH-1 antigen encoded by the CD52 gene.
CD53	A leucocyte restricted tetraspanin expressed by B cells, T cells, dendritic cells, monocytes, NK cells and Granulocytes.
CD54	Intercellular adhesion molecule -1 (ICAM-1): facilitates adhesion between leukocytes and endothelial cells during the immune and inflammatory responses
CD55	Complement Decay-Accelerating Factor (DAF): regulatory factor in one of the three pathways of the immune system complement cascade
CD56	140 kD isoform of NCAM (neural cell adhesion molecule), a marker for natural killer cells and some T-lymphocytes
CD57	Is expressed by Natural Killer Cells subsets of T cells, B Cells, and Monocytes. Represents a carbohydrate epitope that contains a sulfoglucuronyl residue.
CD58	a membrane protein present on many hemopoietic cells and fibroblasts that acts as a ligand for CD2 and may be involved in T-cell function.
CD59	Membrane attack complex inhibition factor (MACIF); MAC-inhibitory protein (MAC-IP); Antigen MEM43; Protectin: Immune system complement cascade regulatory factor; Homologous restriction factor(HRF); Membrane Inhibitor of Reactive Lysis (MIRL)
CD60a	GD3 ganglioside
CD60b	9-O-acetyl-GD3 ganglioside
CD60c	7-O-acetyl-GD3 ganglioside
CD61	Integrin subunit β3; Gene ITGB3. Glycoprotein IIIa (GPIIIa): Component of the integrin αIIbβ3 (GPIIb-IIIa) fibrinogen receptor; major role is in platelet aggregation.^[38] Mutations in ITGB3 can be causative for Glanzmann thrombasthenia.
CD62E	E-selectin is a cell adhesion molecule expressed only on endothelial cells activated by cytokines.
CD62L	L-selectin is a cell adhesion molecule found on leukocytes.
CD62P	P-selectin is a cell adhesion molecule (CAM) found in membrane of Weibel-Palade bodies in endothelial cells (cells lining blood vessels) and in the membrane of the platelet granules. Hence increased expression of CD62P implies platelet activation
CD63	Member of the Tetraspanin family expressed in activated platelets, monocytes and macrophages.
CD64a	Commonly known as Fc-gamma receptor 1 (FcγRI) with high-affinity to IgG. CD64 is found on macrophages and monocytes.
CD65	Ceramide-dodecasaccharide; VIM-2
CD65s	Sialylated-CD65; VIM2
CD66a	CEACAM1 (Carcinoembryonic antigen-related cell adhesion molecule 1)
CD66b	CEACAM8 (Carcinoembryonic antigen-related cell adhesion molecule 8)
CD66c	CEACAM6 (Carcinoembryonic antigen-related cell adhesion molecule 6)
CD66d	CEACAM3 (Carcinoembryonic antigen-related cell adhesion molecule 3)
CD66e	CEACAM5 (Carcinoembryonic antigen-related cell adhesion molecule 5)
CD66f	Pregnancy-specific beta-1-glycoprotein 1 encoded by the PSG1 gene. Produced in high quantity during pregnancy.
CD68	110 kDa highly glycosylated transmembrane protein which is mainly located in lysosomes. Present in macrophages in many human tissues including Kupffer's cells and macrophages in the red pulp of the spleen, in lung alveoli, in lamina propria of the gut, and in the bone marrow. Used as immunocytochemical marker for staining of monocytes/macrophages.
CD69	An early activation marker on T cells and NK cells.
CD70	Expressed on highly activated lymphocytes (like in T- and B-cell lymphomas). Its ligand is CD27.
CD71	Transferrin receptor (Transferrin receptor protein 1 - TfR1), mediates cellular uptake of iron. Ubiquitously expressed on dividing, normal (haematological precursors) and malignant cells. Currently investigated as a target for an antibody ("probody") drug conjugate from Cytomx / Abbvie to treat various cancers.
CD72	Mediator of B-cell - T-cell interactions
CD73	Also known as 5'-ribonucleotide phosphohydrolase. Is expressed on subsets of B-cells and T-cells, endothelial cells, pericytes, follicular dendritic cells, fibroblasts, epithelial cells, cardiomyocytes, neurons, osteoblasts and trophoblasts. Is also expressed on and used as an identification marker of Mesenchymal Stem Cells. Catalyzes the conversion of AMP to bioactive adenosine at neutral pH. Also has functions independent of its enzyme activity and can transmit potent activation signals in T-cells when ligated by antibodies. Upon binding of the antibody on lymphocytes, but not on endothelial cells, CD73 delivers a tyrosine phosphorylation inducing signal. Also functions as a cell adhesion molecule and mediates lymphocyte binding to endothelial cells and adhesion between B-cells and follicular dendritic cells
CD74	Transmembrane protein that assists and maintains the assembly of MHC-II complexes in the ER until its loaded with peptide in Endosomes. Present in all professional APCs expressing MHC-II. It is more commonly named "Invariant chain" and coded in the HLA-II gene cluster.
CD75	lactosamines
CD75s	alpha-2;6-sialylated lactosamines
CD77	ceramide trihexoside
CD79A	Also known as B-cell antigen receptor complex-associated protein alpha chain and MB-1 membrane glycoprotein, is a protein that in humans is encoded by the CD79A gene. Together with CD79B, forms a dimer associated with the formation of the B-cell antigen receptor (BCR), enabling a cell to respond to the presence of antigens on its surface.
CD79B	Also known as B-cell antigen receptor complex-associated protein beta chain, is a protein that in humans is encoded by the CD79B gene. Together with CD79A, forms a dimer associated with the formation of the B-cell antigen receptor (BCR), enabling a cell to respond to the presence of antigens on its surface. Roche is developing an antibody drug conjugate (RG7596) targeting CD76b in certain types of Non-Hogdkin Lymphoma. Macrogenics has started pre-clinical studies into a drug (MGD010) targeting CD79b and CD32b.
CD80	when bound to CD28 on T-cells, can provide the costimulatory effect; also referred to as B7.1, one of the B7 molecules. Causes up-regulation of a high affinity IL-2 receptor allowing T cells to proliferate.
CD81	A tetraspanin expressed in a wide variety of tissues, which plays an important role in B cells as part of the B cell co-receptor complex with CD19, Leu 13 and CD21. Also expressed in T cells, NK cells, Dendritic cells, Monocytes and blood progenitors.
CD82	Member of the tetraspanin family of transmembrane proteins. Broad tissue distribution including B cells, T cells, Granulocytes, Monocytes and CD34+ progenitors.
CD83	a 45 kDa transmembrane glycoprotein of the Ig superfamily. Expressed on cultured dendritic cells, interdigitating, follicular, and circulating dendritic cells as well as some proliferating lymphocyte of all human cell lines. Functionally unclear, but can serve as a useful marker for mature human blood dendritic cells.
CD84	SLAM family member 5 (SLAMF5 - Signaling lymphocytic activation molecule 5) encoded by the CD84 gene. Plays a role as adhesion receptor.
CD85A	LILRB3 - Leukocyte immunoglobulin-like receptor subfamily B member 3
CD85B	LILRB6 - Leukocyte immunoglobulin-like receptor subfamily B member 6
CD85C	LILRB5 - Leukocyte immunoglobulin-like receptor subfamily B member 5. Detected in natural killer (NK) cells.
CD85D	LILRB2 - Leukocyte immunoglobulin-like receptor subfamily B member 2
CD85F	LILRB7 - Leukocyte immunoglobulin-like receptor subfamily B member 7
CD85G	LILRA4 - Leukocyte immunoglobulin-like receptor subfamily A member 4
CD85H	LILRA2 - Leukocyte immunoglobulin-like receptor subfamily A member 2
CD85I	LILRA1 - Leukocyte immunoglobulin-like receptor subfamily A member 1
CD85J	LILRB1 - Leukocyte immunoglobulin-like receptor subfamily B member 1
CD85K	LILRB4 - Leukocyte immunoglobulin-like receptor subfamily B member 4
CD85M	LILRP2 LILRA5 - leukocyte immunoglobulin-like receptor subfamily A (without TM domain); member 5
CD86	when bound to CD28 on T-cells, can provide the costimulatory effect; also referred to as B7.2, one of the B7 molecules. Causes up-regulation of a high affinity IL-2 receptor allowing T cells to proliferate.
CD87	also referred to as the urokinase type plasminogen activator receptor, provides a binding point for urokinase type plasminogen activator
CD88	C5a receptor
CD89	FcalphaRI - receptor for IgA
CD90	Thy-1 Thymus cell antigen.
CD91	Low density lipoprotein (LDL) receptor-related protein 1 (LRP1) (also known as α2-macroglobulin receptor), a major endocytotic receptor with over 35 known ligands including amyloid precursor protein (APP), ApoE, and many proteins involved with protease regulation
CD92	Choline transporter-like protein 1 (CTL1) encoded by the SLC44A1 gene
CD93	Complement component C1q receptor (C1QR1) encoded by the CD93 gene
CD94	Natural killer cells antigen CD94, encoded by the KLRD1 gene. Plays a role as a receptor for the recognition of MHC class I HLA-E molecules by NK cells and some cytotoxic T-cells.
CD95	Fas Receptor, encoded by FAS gene; receptor for Fas ligand (CD178 - FASLG), an extrinsic apoptotic signal i.e. Fas ligand binding to Fas receptor leads to apoptosis - death of the cell. Fas ligand/receptor interactions play an important role in the regulation of the immune system and the progression of cancer.
CD96	CD96 is a transmembrane glycoprotein that has three extracellular immunoglobulin-like domains and is expressed by all resting human and mouse NK cells. CD96 main ligand is CD155. CD 96 has approximately 20% homology with CD226 and competed for binding to CD155 with CD226.
CD97	CD97 antigen encoded by the CD97 gene. Receptor potentially involved in both adhesion and signaling processes early after leukocyte activation. Plays an essential role in leukocyte migration
CD98	is a glycoprotein that is a heterodimer composed of SLC3A2 and SLC7A5 that forms the large neutral amino acid transporter (LAT1). LAT1 is a heterodimeric membrane transport protein that preferentially transports branched-chain (valine, leucine, isoleucine) and aromatic (tryptophan, tyrosine) amino acids. LAT is highly expressed in brain capillaries (which form the blood–brain barrier) relative to other tissues. A functional LAT1 transporter is composed of two proteins encoded by two distinct genes:4F2hc/CD98 heavy subunit protein encoded by the SLC3A2 gene CD98 light subunit protein encoded by the SLC7A5.
CD99	Also known as MIC2 or single-chain type-1 glycoprotein, is a heavily O-glycosylated transmembrane protein. Unusually for a gene present on the X chromosome, the CD99 gene does not undergo X inactivation. It is expressed on all leukocytes but highest on thymocytes and is believed to augment T-cell adhesion and apoptosis of double positive t cells. It also participates in migration and activation. Also used to distinguish between various hematological malignancies.
CD100	Also known as semaphorin 4D and is known as a potent proangiogenic molecule.
CD101	Also known as IGSF2 or V7. It participates in human T-cell activation and is expressed by human skin dendritic cells
CD102	Intercellular adhesion molecule 2, encoded by ICAM2 gene.
CD103	A type I transmembrane protein present on intestinal intraepithelial lymphocytes, some circulating leukocytes, and some T cells that facilitates adhesion to epithelia; expressed in hairy cell leukemia and some B-cell chronic lymphocytic leukemias.
CD104	Integrin beta-4 (ITB4), encoded by the ITGB4 gene; receptor for laminin; structural role in epithelial cells; required for regulation of keratinocyte polarity and motility
CD105	Endoglin, a regulatory component of the TGF-beta receptor-cell complex. Mediates cellular response to TGFbeta.
CD106	VCAM-1; Alpha 4 beta 1 ligand. Adhesion molecule involved in white blood cell migration.
CD107*	Found on Platelets
CD107a	Lysosome-associated Membrane Protein 1 (LAMP1)
CD107b	Lysosome-associated Membrane Protein 2 (LAMP2)
CD108	Semaphorin-7A, encoded by SEMA7A gene; also known as the John-Milton-Hagen (JMH) blood group antigen, a glycoprotein expressed on activated lymphocytes and erythrocytes
CD109	r150, Gov alloantigen, an accessory receptor of the TGF-beta signaling pathway. Mediates cellular response to TGFbeta. Presents Gov alloantigens and ABH blood antigens.
CD110	Thrombopoietin receptor (TPOR), encoded by the MPL (myeloproliferative leukemia virus) gene; mutations in gene associated with forms of anemia, myelofibrosis and thrombocythemia.
CD111	Nectin-1 or Herpesvirus entry mediator C (HveC), encoded by the PVRL1 (Poliovirus receptor-related protein 1) gene. Key role in cellular entry of Herpes simplex virus.
CD112	Nectin-2 or Herpesvirus entry mediator B (HveB), encoded by the PVRL2 (Poliovirus receptor-related protein 2) gene. Involved in entry for some herpes simplex strains and pseudorabies. Variations in gene linked to severity of multiple sclerosis.
CD113	Nectin-3, encoded by the PVRL3 (Poliovirus receptor-related protein 3) gene. Role in cell-cell adhesion
CD114	Granulocyte colony-stimulating factor receptor (GCSFR), encoded by the CSF3R gene; essential for granulocytic maturation
CD115	a cell-surface protein encoded, in humans, by the CSF1R gene. Also known as colony stimulating factor 1 receptor (CSF1R) and/or as macrophage colony-stimulating factor receptor (M-CSFR). It is a receptor, known to be expressed on monocytes and macrophages, for a cytokine called colony stimulating factor 1 (CSF1) and also interleukin 34 (IL34). Binding to CSF1 and IL34 ligands activate CSF1R, promoting survival and activity of monocytes and macrophages. Five Prime has an early stage drug, FPA008, that blocks CSF1R in the hope of treating macrophage-dependent diseases including cancers and rheumatoid arthritis - in trials with Nivolumab. Roche also has an experimental anti-CD115 mAb, Emactuzumab.^[40]
CD116	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (GMR-alpha); encoded by the CSF2RA gene
CD117	c-kit, the receptor for Stem Cell Factor, a glycoprotein that regulates cellular differentiation, particularly in hematopoiesis
CD118	Leukemia inhibitory factor receptor, encoded by the LIFR gene; signal-transducing molecule
CD119	Interferon gamma receptor 1, encoded by the IFNGR1 gene; receptor for interferon gamma - two receptors bind one interferon gamma dimer.
CD120*	a receptor for Tumour Necrosis Factor, an inflammatory cytokine
CD120a	Tumor necrosis factor receptor superfamily member 1A (TNFR1), encoded by TNFRSF1A gene. Familial hibernian fever is caused by mutations in this gene.
CD120b	Tumor necrosis factor receptor superfamily member 1B (TNFR2), encoded by TNFRSF1B gene. Constituent of the drug Enbrel, used to treat rheumatoid arthritis.
CD121a	Interleukin-1 receptor type 1, encoded by IL1R1 gene; cytokine receptor
CD121b	Interleukin-1 receptor type 2, encoded by IL1R2 gene; cytokine receptor
CD122	beta subunit of IL-2 receptor
CD123	Also known as interleukin-3 receptor (IL-3R), is a molecule found on cells which helps transmit the signal of interleukin-3, a soluble cytokine important in the immune system. It is found on pluripotent progenitor cells, induces tyrosine phosphorylation within the cell, and promotes proliferation and differentiation within the hematopoietic cell lines.
CD124	Interleukin-4 receptor subunit alpha; encoded by IL4R gene. Receptor for both interleukin 4 and interleukin 13. IL4Ra is targeted by Regeneron-Sanofi antibody Dupilumab in the treatment of atopic dermatitis^[41] and Pieris-Astra Zeneca investigational anticalin PRS-060 in the treatment of asthma.^[42] Both drugs thus modulate signaling of the interleukin 4 and interleukin 13 pathways.
CD125	Interleukin-5 receptor subunit alpha; encoded by IL5RA gene.
CD126	Interleukin-6 receptor subunit alpha; encoded by IL6R gene.
CD127	the IL-7 receptor alpha chain
CD129	Interleukin-9 receptor; encoded by IL9R gene
CD130	Interleukin-6 receptor subunit beta (IL6RB); encoded by IL6ST gene; signal-transducing molecule
CD131	Cytokine receptor common subunit beta; encoded by CSF2RB gene; high affinity receptor for interleukin-3, interleukin-5 and granulocyte-macrophage colony-stimulating factor. Gene mutation can cause a rare lung disorder.
CD132	Cytokine receptor common subunit gamma, or gamma subunit of IL-2 receptor (IL2RG). Gene mutation can cause rare x-linked immunodeficiency.
CD133	Prominin-1, (PROM1 gene); a hematopoietic and CNS stem cell marker. A 5 transmembrane domain protein. Also known as AC133. Gene mutations can cause various retinal diseases. Also found in various body fluids such as cerebrospinal fluid, saliva, seminal fluid and urine.
CD134	Tumor necrosis factor receptor superfamily member 4 (TNFRSF4), also known as OX40; a T-cell secondary costimulatory molecule which enhances proliferation, cytokine production and survival; its ligand OX40L, or CD252, binds to OX40 receptors on T-cells, preventing them from dying and subsequently increasing cytokine production. Without CD28, OX40 expression is delayed and reduced. OX40 also binds TRAF2, 3 and 5 and PI3K. OX40 gene mutations can cause a type of immunodeficiency. Roche has an experimental monoclonal antibody in development that targets OX40 (RG7888); anti-OX40 functions as an agonist antibody, which results in activation rather than blockade of the OX40 signaling pathway upon receptor binding; Medimmune AstraZeneca is developing 3 drugs targeting OX40 in colorectal, prostate, breast, and head and neck cancers; MEDI6383, MEDI0562, and MEDI6469
CD135	Also known as fms-like tyrosine kinase receptor-3 (Flt3) or fetal liver kinase-2 (Flk2); A cytokine receptor for Flt3 ligand (Flt3L) important in early hematopoiesis. Gene may be involved in acute myelogenous leukemia (AML).
CD136	Macrophage-stimulating protein receptor, (MST1R gene); binds to MST1 ligand;
CD137	Tumor necrosis factor receptor superfamily member 9 (TNFRSF9), a member of the tumor necrosis factor (TNF) receptor family, also known as 4-1BB and Induced by Lymphocyte Activation (ILA). Targeted by Bristol Myers' Urelumab, a CD137 agonist antibody, in early trials with anti-PDL1 (CD274) mAbs; activating CD137 stimulates an immune response, in particular a cytotoxic T cell response, against tumor cells, though liver toxicity can be a problematic side effect. Pfizer also has an early-stage 4-1BB agonist (Utomilumab PF-2566) in combination trials, and Pieris is trialling PRS-343, a CD137 - HER2 bispecific (2016).^[43]
CD138	a plasma cell-surface glycoprotein, known as syndecan-1. Syndecan functions as the alpha receptor for collagen, fibronectin and thrombospondin.
CD139	not assigned
CD140A	also known as Platelet-derived growth factor receptor, alpha (PDGFRA); a protein in humans encoded by PDGFRA gene. A cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. Lilly has developed Olaratumab, (LY3012207) a human IgG1 monoclonal antibody designed to bind to human PDGFRα with high affinity and block PDGF-AA, PDGF-BB, and PDGF-CC ligands from binding to the receptor and is conducting clinical trials in patients with soft-tissue sarcoma.^[44]
CD140B	also known as Platelet-derived growth factor receptor, beta (PDGFRB); a protein in humans encoded by PDGFRB gene. A cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family.
CD141	Thrombomodulin or BDCA-3, an integral membrane protein. On endothelial cells, it is involved in anticoagulation. It also occurs, with unknown function, on a very rare subtype of dendritic cells.
CD142	Tissue factor, a major initiator of blood-clotting
CD143	Angiotensin-converting enzyme
CD144	VE-Cadherin, a calcium-dependent adhesion molecule at intercellular junctions, found mainly in the vascular endothelium. Recent research indicates that CD144 may be present on some leucocytes as well.
CDw145	not assigned ?
CD146	Cell surface glycoprotein MUC18; encoded by MCAM (Melanoma cell adhesion molecule) gene; expression may allow melanoma cells to interact with cellular elements of vascular system, thus enhancing tumor spread
CD147	Neurothelin. An extracellular matrix metalloproteinase inducer.
CD148	Receptor-type tyrosine-protein phosphatase eta; encoded by PTPRJ gene;
CD150	Signaling lymphocytic activation molecule; encoded by SLAMF1 gene; important in bidirectional T-cell to B-cell stimulation; acts as a receptor for measles virus
CD151	Tetraspanin with a wide tissue distribution, including platelets, Megakaryocytes, Granulocytes and erythroleukemia.
CD152	Also called Cytotoxic T-lymphocyte antigen-4 (CTLA-4). Expressed in CD4+ T Lymphocytes but also found in some B Lymphocytes. Binds to CD80 and CD86 receptors with a higher affinity than CD28, and inhibits T cell activation. Targeted by drugs such as Ipilimumab for melanoma and other cancers.
CD153	Tumor necrosis factor ligand superfamily member 8; encoded by TNFSF8 gene; CD30 ligand; induces proliferation of T-cells.
CD154	The ligand for CD40. This is a costimulatory molecule that plays many roles, best known for activating B cells but also known to induce the activation of an APC in association with T cell receptor stimulation by MHC molecules on the APC.
CD155	The poliovirus receptor, a protein that in humans that is encoded by the PVR gene. Also known as Necl5.
CD156*	A member of A Disintegrin And Metalloprotease family
CD156a	Disintegrin and metalloproteinase domain-containing protein 8; encoded by ADAM8 gene
CD156b	Disintegrin and metalloproteinase domain-containing protein 17; encoded by ADAM17 gene
CD156c	Disintegrin and metalloproteinase domain-containing protein 10; encoded by ADAM10 gene
CD157	BST1 Bone marrow stromal cell antigen-1 is a stromal cell line-derived glycosylphosphatidylinositol-anchored molecule that facilitates pre-B-cell growth. The deduced amino acid sequence exhibits 33% similarity with CD38. BST1 expression is enhanced in bone marrow stromal cell lines derived from patients with rheumatoid arthritis.
CD158*	Killer cell immunoglobulin-like receptors (KIR) with two extracellular domains, variously expressed on NK cells. CD158a is KIR2DL1, CD158b is KIR2DL3, CD158d is KIR2DL4. Innate and Bristol Myers are testing monoclonal antibody Lirilumab, which binds to KIR2DL1 (CD158A) and KIR2DL2/3, thus blocking the interaction of KIR receptors with their HLA-C ligands, and preventing the inhibitory signal triggered by this interaction. Thus the cytotoxicity of NK cells is enhanced.
CD158A	Killer cell immunoglobulin-like receptor 2DL1; encoded by KIR2DL1 gene; receptor on natural killer cells for HLA-C alleles; inhibits the activity of NK cells thus preventing cell lysis.
CD158B1	Killer cell immunoglobulin-like receptor 2DL2; encoded by KIR2DL2 gene; receptor on NK cells for HLA-Cw1, 3, 7, and 8 allotypes; inhibits activity of NK cells thus preventing cell lysis
CD158B2	Killer cell immunoglobulin-like receptor 2DL3; encoded by KIR2DL3 gene; receptor on natural killer cells for HLA-C alleles; inhibits activity of NK cells thus preventing cell lysis
CD158C	Putative killer cell immunoglobulin-like receptor like protein KIR3DP1; encoded by KIR3DP1 gene; expressed in peripheral blood cells
CD158D	Killer cell immunoglobulin-like receptor 2DL4; encoded by KIR2DL4 gene; receptor on NK cells for HLA-C alleles; inhibits NK cell activity thus prevents cell lysis.
CD158E1	Killer cell immunoglobulin-like receptor 3DL1; encoded by KIR3DL1 gene; receptor on natural killer (NK) cells for HLA Bw4 allele; inhibits NK cell activity thus prevents cell lysis.
CD158E2	Killer cell immunoglobulin-like receptor 3DS1; encoded by KIR3DS1 gene; receptor on natural killer (NK) cells for HLA-C alleles; does not inhibit activity of NK cells.
CD158F1	Killer cell immunoglobulin-like receptor 2DL5A; encoded by KIR2DL5A gene; inhibits NK cell activity thus prevents cell lysis. **
CD158F2	Killer cell immunoglobulin-like receptor 2DL5B; encoded by KIR2DL5B gene; inhibits NK cell activity thus prevents cell lysis. **
CD158G	Killer cell immunoglobulin-like receptor 2DS5; encoded by KIR2DS5 gene; receptor on natural killer (NK) cells for HLA-C alleles; does not inhibit activity of NK cells.
CD158H	Killer cell immunoglobulin-like receptor 2DS1; encoded by KIR2DS1 gene; receptor on natural killer (NK) cells for HLA-C alleles; does not inhibit activity of NK cells.
CD158I	Killer cell immunoglobulin-like receptor 2DS4; encoded by KIR2DS4 gene; receptor on natural killer (NK) cells for HLA-C alleles; does not inhibit activity of NK cells.
CD158J	Killer cell immunoglobulin-like receptor 2DS2; encoded by KIR2DS2 gene; receptor on natural killer (NK) cells for HLA-C alleles; does not inhibit activity of NK cells.
CD158K	Killer cell immunoglobulin-like receptor 3DL2; encoded by KIR3DL2 gene; receptor on natural killer (NK) cells for HLA-A alleles; inhibits activity of NK cells thus prevents cell lysis
CD159a	NKG2-A/NKG2-B type II integral membrane protein; encoded by KLRC1 gene; receptor for recognition of MHC class I HLA-E molecules by NK cells and some cytotoxic T-cells
CD159c	NKG2-C type II integral membrane protein; encoded by KLRC2 gene
CD160	CD160 expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. In tissues, CD160 is expressed on all intestinal intraepithelial lymphocytes. CD160 shows a broad specificity for binding to both classical and nonclassical MHC class I molecules.
CD161	Killer cell lectin-like receptor subfamily B member 1; encoded by KLRB1 gene; inhibitory role in natural killer cell cytotoxicity
CD162	P-selectin glycoprotein ligand 1; encoded by SELPLG gene; also receptor for enterovirus 71
CD163	M130; HbSR; RM3/1 antigen. A glycoprotein endocytic scavenger receptor for haptoglobin-hemoglobin complexes. Found specifically on monocytes/macrophages and some dendritic cells. Involved in anti-inflammatory processes. Soluble form shed upon Toll-like receptor activation.
CD164	Sialomucin core protein 24 (MUC24) or endolyn; encoded by CD164 gene; implicated in hematopoiesis, prostate cancer metastasis and infiltration of bone marrow by cancer cells
CD165	SN2, cell surface glycoprotein used to monitor platelet function; strongly expressed on T cell type acute lymphoblastic cells and most platelets
CD166	activated leukocyte cell adhesion molecule (ALCAM); ligand for CD6 and involved in neurite extension
CD167a	Epithelial discoidin domain-containing receptor 1, encoded by DDR1 gene; tyrosine kinase that functions as cell surface receptor for fibrillar collagen; abundant in some carcinomas;
CD167b	Discoidin domain-containing receptor 2, encoded by DDR2 gene; tyrosine kinase that functions as cell surface receptor for fibrillar collagen and regulates cell differentiation, remodeling of the extracellular matrix, cell migration and cell proliferation. Required for normal bone development; mutations in gene can cause a form of dwarfism.
CD168	Hyaluronan mediated motility receptor (RHAMM), encoded by HMMR gene; over expressed in some cancers.
CD169	Sialoadhesin^[45] (SN); encoded by SIGLEC1 gene; a cell adhesion protein on macrophages that binds to sialic acids
CD170	Sialic acid-binding Ig-like lectin 5 or SIGLEC5; putative adhesion molecule that mediates sialic-acid dependent binding to cells
CD171	Neural cell adhesion molecule L1, encoded by L1CAM gene; cell adhesion molecule with important role in development of nervous system; involved in neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites, etc. Binds to axonin on neurons. Gene mutations can cause hydrocephalus. Juno Therapeutics has an experimental anti-CD171 CAR-T therapy in development to treat Neuroblastoma.
CD172a	Tyrosine-protein phosphatase non-receptor type substrate 1, also known as SIRPa (Signal Regulatory Protein Alpha); acts as inhibitory transmembrane receptor with CD47 resulting in inhibition of phagocytosis ("don't eat me"), stimulation of cell-cell fusion, and T-cell activation. Component of SIRPaFc, an experimental drug aimed at AML
CD172b	Signal-regulatory protein beta-1, encoded by SIRPB1 gene. Immunoglobulin-like cell surface receptor involved in the negative regulation of receptor tyrosine kinase-coupled signaling processes. Participates also in the recruitment of tyrosine kinase SYK.
CD172g	Signal-regulatory protein gamma (or beta-2), encoded by SIRPG or SIRPB2 gene. Binds with CD47.
CD173	Blood Group H^[46]
CD174	Fucosyltransferase 3 (Lewis FT), enzyme encoded by FUT3 gene; may be involved in blood group Lewis determination
CD175	Tn antigen^[47]
CD175s	Sialyl-Tn antigen^[48] (STN)
CD176	TF^[49] or Thomsen–Friedenreich antigen is a disaccharide found on cell surfaces and released into circulation in many cancers.
CD177	CD177 antigen expressed by CD177 gene; also polycythemia rubra vera 1 (PRV1) or NB1 glycoprotein (NB1 GP). Highly expressed in normal bone marrow, also in granulocytes of patients with polycythemia vera (PV) and with essential thrombocythemia (ET)
CD178	Fas ligand (FasL) is a type-II transmembrane protein belonging to the tumor necrosis factor (TNF) family. Its binding with its receptor Fas (CD95) induces apoptosis. Fas ligand/receptor interactions play an important role in the regulation of the immune system and the progression of cancer.
CD179a	Immunoglobulin iota chain, encoded by VPREB1 gene; associates with Ig-mu chain to form complex expressed on surface of pre-B-cells; presumably regulates Ig gene rearrangements during B-cell differentiation.
CD179b	Immunoglobulin lambda-like polypeptide 1, encoded by IGLL1 gene; critical for B-cell development
CD180	CD180 antigen or LY64, encoded by CD180 gene; may cooperate with MD-1 and TLR4 to mediate innate immune response to bacterial lipopolysaccharide in B-cells
CD181	CXC chemokine receptor type 1, encoded by CXCR1 gene (old name IL8RA); receptor to interleukin-8. Blocking CXCR1 can inhibit some cancers
CD182	CXC chemokine receptor type 2, encoded by CXCR2 gene (old name IL8RB); receptor for interleukin-8
CD183	CXC chemokine receptor type 3, encoded by CXCR3 gene; receptor for CXCL9, CXCL10 and CXCL11 and mediates the proliferation, survival and angiogenic activity of human mesangial cells; implicated in a wide variety of diseases
CD184	CXC chemokine receptor type 4, encoded by CXCR4 gene; receptor for chemokine Stromal Derived Factor 1 (CXCL12 or SDF-1); involved in mesenchymal stem cell homing and migration; acts as a coreceptor (with CD4) for HIV-1
CD185	CXC chemokine receptor type 5, encoded by CXCR5 (or Burkitt lymphoma receptor 1, BLR1) gene; may have a regulatory function in Burkitt lymphoma
CD186	CXC chemokine receptor type 6, encoded by CXCR6 gene; a G-protein-coupled receptor for the chemokine CXCL16; used as a coreceptor by SIVs and strains of HIV-2 and m-tropic HIV-1
CD187	not assigned
CD188	not assigned
CD189	not assigned
CD190	not assigned
CD191	CC chemokine receptor type 1, also Macrophage inflammatory protein 1-alpha receptor, encoded by CCR1 gene; affects stem cell proliferation
CD192	CC chemokine receptor type 2, encoded by CCR2 gene; receptor for CCL2, CCL7 and CCL13 chemokines; alternative coreceptor with CD4 for HIV-1 infection
CD193	CC chemokine receptor type 3, encoded by CCR3 gene; eosinophil eotaxin receptor; alternative coreceptor with CD4 for HIV-1 infection
CD194	CC chemokine receptor type 4, encoded by CCR4 gene; high affinity receptor for CCL17, CCL22 and CKLF1 chemokines; could mediate hippocampal-neuron survival
CD195	CC chemokine receptor type 5, encoded by CCR5 gene; a beta chemokine receptor to which the natural chemokine ligands RANTES and macrophage inflammatory protein bind. It is commonly used by HIV as a co-receptor to enter its target cells.
CD196	CC chemokine receptor type 6, encoded by CCR6 gene; receptor for MIP-3-alpha or LARC
CD197	CC chemokine receptor type 7, encoded by CCR7 gene; a beta chemokine receptor to which chemokines involved in the migration of T lymphocytes across high endothelial venules bind.
CDw198	CC chemokine receptor type 8, encoded by CCR8 gene; receptor for CCL1; coreceptor for HIV-1
CDw199	CC chemokine receptor type 9, encoded by CCR9 gene; a beta chemokine receptor involved in mucosal immunity. The specific ligand of this receptor is CCL25.
CD200	Also known as OX-2, a type-1 membrane glycoprotein belonging to the immunoglobulin superfamily. May regulate myeloid cell activity and delivers an inhibitory signal for the macrophage lineage in diverse tissues. CD200 is overexpressed by many different types of hematological and solid tumors. Biotech company Trillium has developed an investigative anti-CD200 monoclonal antibody.
CD201	Endothelial protein C receptor (EPCR), also known as activated protein C receptor (APC receptor), is a protein encoded by the PROCR gene. Mutations in this gene have been associated with venous thromboembolism, myocardial infarction and late fetal loss during pregnancy. The protein is also involved in Plasmodium falciparum malaria as subtypes of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family use EPCR of the host as a receptor.
CD202b	Angiopoietin-1 receptor, TEK or TIE2;^[50] encoded by the TEK gene. TEK receptor tyrosine kinase is expressed almost exclusively in endothelial cells. The ligand for the receptor is angiopoietin-1. Defects in TEK are associated with inherited venous malformations; the TEK signaling pathway appears to be critical for endothelial cell-smooth muscle cell communication in venous morphogenesis. TEK is closely related to the TIE receptor tyrosine kinase
CD203a	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1); this protein belongs to a series of ectoenzymes involved in hydrolysis of extracellular nucleotides, notably ATP and NAD, which can contribute to the formation of adenosine in cancer.
CD203c	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3); this protein belongs to a series of ectoenzymes involved in hydrolysis of extracellular nucleotides, which possess ATPase and ATP pyrophosphatase activities and are type II transmembrane proteins. Found in uterus, basophils, and mast cells.
CD204	Macrophage scavenger receptor 1 (MSR1) or SCARA1; able to mediate endocytosis of modified low density lipoproteins (LDLs); group implicated in macrophage-associated physiological and pathological processes including atherosclerosis, Alzheimer's disease and host defense.
CD205	Also known as Lymphocyte antigen 75 (LY75), a protein that in humans is encoded by the LY75 gene. Also known as DEC-205.
CD206	Also known as Mannose receptor C-type 1 (MC1) and present on the surface of macrophages, immature dendritic cells, and surface of skin cells such as human dermal fibroblasts and keratinocytes. Additional functions include clearance of glycoproteins from the circulation.
CD207	Langerin is a type II transmembrane, C-type lectin receptor on Langerhans cells. Also known as C-type lectin domain family 4 member K. Langerin is localized in the Birbeck granules, organelles present in the cytoplasm of Langerhans cells.
CD208	Also known as Lysosome-associated membrane glycoprotein 3 (LAMP3). A protein that in humans is encoded by the LAMP3 gene.
CD209	DC-SIGN, C-type lectin receptor found on dendritic cell subsets
CD210	Interleukin-10 receptor subunit alpha (IL10RA gene) is shown to mediate the immunosuppressive signal of interleukin 10 and thus inhibit synthesis of proinflammatory cytokines. Mutations in the gene implicated in forms of inflammatory bowel disease
CDw210a	Interleukin-10 receptor subunit alpha (IL10RA gene) is shown to mediate the immunosuppressive signal of interleukin 10 and thus inhibit synthesis of proinflammatory cytokines. Mutations in the gene implicated in forms of inflammatory bowel disease.^[51]
CDw210b	Interleukin-10 receptor subunit beta (IL10RB gene); required for activation of cytokines: IL10, IL22, IL26, IL28, and IFNL1. Mutation in the gene associated with a form of IBD.^[52]
CD211	not assigned
CD212	IL12RB1 - Interleukin 12 receptor, beta 1; a subunit of the interleukin 12 receptor. Lack of expression found to result in the immunodeficiency of patients with severe mycobacterial and Salmonella infections
CD213a1	IL13RA1 - Interleukin 13 receptor, alpha 1; a subunit of the interleukin 13 receptor. This protein has been shown to bind tyrosine kinase TYK2, and thus may mediate signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4
CD213a2	IL13RA2 - Interleukin-13 receptor subunit alpha-2
CD214	not assigned
CD215	IL15RA - Interleukin 15 receptor, alpha subunit
CD216	not assigned
CD217	IL17R - Interleukin-17 receptor; a cytokine receptor which binds interleukin 17A.
CD218a	IL18R1 - interleukin-18 receptor 1
CD218b	IL18RAP - Interleukin 18 receptor accessory protein. Variants at IL18RAP have been linked to susceptibility to Coeliac disease.
CD219	not assigned
CD220	The insulin receptor (INSR) is a transmembrane receptor with intrinsic tyrosine kinase activity whose ligand is insulin. It plays a crucial role in the regulation of various metabolic pathways, as well as regulating aspects of the cell cycle, such as cellular growth, differentiation, and apoptosis. Mutations in the insulin receptor have been found to be associated with both Type 1 and Type 2 Diabetes Mellitus.
CD221	IGF-I-receptor (IGF1R) - insulin-like growth factor 1 receptor
CD222	IGF2R - Insulin-like growth factor 2 receptor, also called the cation-independent mannose-6-phosphate receptor (CI-MPR)
CD223	Lymphocyte Activation Gene 3 (LAG3), an inhibitory (checkpoint) receptor on immune system T-cells. LAG3 is the target of early-stage drugs for cancer and autoimmune disorders; IMP321 is a soluble version of LAG3, developed by Prima, while BMS-986016 (from Bristol Myers) and GSK2831781 (Glaxo) are anti-LAG3 monoclonal antibodies.
CD224	GGT1 - Gamma-glutamyltransferase 1
CD225	IFITM1 - Interferon-induced transmembrane protein 1. IFITM proteins have been identified as antiviral restriction factors for influenza A virus replication
CD226	A co-stimulatory molecule found on Natural Killer Cells, also potentially responsible for cellular adhesion between a NK cell and its cytolytic target.
CD227	MUC1 - Mucin 1, cell surface associated or polymorphic epithelial mucin (PEM) is a mucin encoded by the MUC1 gene in humans. The protein serves a protective function by binding to pathogens and also functions in a cell signaling capacity. Used in histopathology, where it is known as EMA (epithelial membrane antigen), to identify various tumours etc.
CD228	Melanotransferrin (MFI2). This protein is a cell-surface glycoprotein found on melanoma cells
CD229	LY9 - T-lymphocyte surface antigen; SLAMF3
CD230	PRNP - Major prion protein or PrP, for prion protein or protease-resistant protein). More than 20 mutations in the PRNP gene have been identified in people with inherited prion diseases.
CD231	Tetraspanin-7 - TSPAN7. The associated gene is linked to X-linked mental retardation and neuropsychiatric diseases such as Huntington's chorea, fragile X syndrome and myotonic dystrophy.
CD232	Plexin-C1^[53] (PLXNC1 gene); also called Virus-encoded semaphorin protein receptor (VESPR); Receptor for several virus semaphorins.
CD233	known as SLC4A1 (solute carrier family 4 member 1), anion exchanger 1 (AE1) or band 3 (BND3); present in the principal acid secreting cell of the kidney and red blood cells
CD234	DARC - Duffy antigen/chemokine receptor; located on the surface of red blood cells; receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi.
CD235a	Glycophorin A, a protein on blood cells; GYPA
CD235b	Glycophorin B (MNS blood group); GYPB
CD236	Glycophorin C - GYPC
CD237	not assigned
CD238	Kell blood group - KEL
CD239	LU - Lutheran blood group; Basal cell adhesion molecule (BCAM)
CD240CE	RHCE - Blood group Rh(CE) polypeptide.
CD240D	RHD - Rh blood group, D antigen, also known as Rh polypeptide 1 (RhPI). The RhD erythrocyte membrane protein is the Rh factor antigen of the Rh blood group system.
CD241	RHAG - Rh-associated glycoprotein is an ammonia transporter protein encoded by the RHAG gene. Mutations in this gene can cause stomatocytosis.
CD242	known as ICAM4 (Intercellular Adhesion Molecule-4) or LW (Landsteiner-Wiener blood group)
CD243	known as ABCB1 (ATP-binding cassette sub-family B member 1), P-glycoprotein 1 (permeability glycoprotein, P-gp or Pgp) or MDR1 (multidrug resistance protein 1); an important protein of the cell membrane that pumps many foreign substances out of cells.
CD244	Also known as 2B4, it encodes a cell surface receptor expressed on natural killer (NK) cells (and some T cells) mediating non-major histocompatibility complex (MHC) restricted killing. Thought to modulate NK-cell cytolitic activity.
CD245^[54]	not assigned ?
CD246	ALK - Anaplastic lymphoma kinase or ALK tyrosine kinase receptor. ALK plays an important role in the development of the brain. Several ALK-inhibitor drugs are used to treat lung cancer. ALK is also overexpressed in several other tumours.
CD247	CD3-ZETA - T-cell surface glycoprotein CD3 zeta chain
CD248	Endosialin is a member of the “Group XIV”, a novel family of C-type lectin transmembrane receptors which play a role not only in cell-cell adhesion processes but also in host defence
CD249	Glutamyl aminopeptidase - ENPEP. The enzyme degrades vasoconstricting angiotensin II into angiotensin III and so helps to regulate blood pressure.
CD250	not assigned
CD251	not assigned
CD252	OX40L or TNFSF4 (tumor necrosis factor (ligand) superfamily, member 4), the ligand for CD134 (OX40) and expressed on cells such as DC2s (a subtype of dendritic cells) enabling amplification of Th2 cell differentiation. Various single nucleotide polymorphisms (SNPs) of the OX40L gene have been identified, some associated with systemic lupus erythematosus, but not atherosclerosis.
CD253	TRAIL (TNF-related apoptosis-inducing ligand), or TNFSF10 (tumor necrosis factor (ligand) superfamily, member 10). TRAIL is a cytokine produced by most normal tissue cells, causing apoptosis primarily in tumor cells by binding to certain death receptors. The target of several anti-cancer therapeutics since mid-1990s, but these have not shown significant survival benefit.
CD254	RANKL (Receptor activator of nuclear factor kappa-B ligand), tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF). RANKL affects the immune system and controls bone regeneration. Targeted by mAb drug Denosumab to treat osteoporosis.
CD255	not assigned
CD256	APRIL (proliferation-inducing ligand) or TNFSF13 (tumor necrosis factor ligand superfamily member 13); a protein of the TNF superfamily recognized by the cell surface receptor TACI (CD267) - both found to be important for B cell development
CD257	BAFF (B-cell activating factor) or TNFSF13B (tumor necrosis factor ligand superfamily member 13B). This cytokine is a ligand for receptors TNFRSF13B/TACI (CD267), TNFRSF17/BCMA (CD269), and TNFRSF13C/BAFF-R (CD268). Expressed in B cell lineage cells, and acts as a potent B cell activator
CD258	LIGHT (homologous to Lymphotoxin, exhibits Inducible expression and competes with HSV Glycoprotein D for binding to Herpesvirus entry mediator, a receptor expressed on T lymphocytes), or TNFSF14 (tumor necrosis factor superfamily member 14); a secreted protein of the TNF superfamily; recognized by herpesvirus entry mediator, HVEM or CD270, thus aka HVEML. Also interacts with decoy receptor 3, BIRC2, TRAF2 and TRAF3.
CD259	not assigned
CD260	not assigned
CD261	Death receptor 4 (DR4), TRAIL receptor 1 (TRAILR1) and tumor necrosis factor receptor superfamily member 10A (TNFRSF10A); a cell surface receptor of the TNF-receptor superfamily that binds TRAIL (CD253) and mediates apoptosis.
CD262	Death receptor 5 (DR5), TRAIL receptor 2 (TRAILR2) and tumor necrosis factor receptor superfamily member 10B (TNFRSF10B); a cell surface receptor of the TNF-receptor superfamily that binds TRAIL (CD253) and mediates apoptosis.
CD263	Decoy receptor 1 (DCR1), TRAIL receptor 3 (TRAILR3) and tumor necrosis factor receptor superfamily member 10C (TNFRSF10C); a human cell surface receptor of the TNF-receptor superfamily; not capable of inducing apoptosis, and thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis
CD264	Decoy receptor 2 (DCR2), TRAIL receptor 4 (TRAILR4) and tumor necrosis factor receptor superfamily member 10D (TNFRSF10D); a human cell surface receptor of the TNF-receptor superfamily; does not induce apoptosis, and plays inhibitory role in TRAIL-induced cell apoptosis
CD265	RANK (Receptor Activator of Nuclear Factor κ B), TRANCE Receptor or TNFRSF11A; member of the tumor necrosis factor receptor (TNFR) molecular sub-family. RANK is the receptor for RANK-Ligand (RANKL). It is associated with bone remodeling and repair, immune cell function, lymph node development, thermal regulation, and mammary gland development
CD266	TNFRSF12A (Tumor necrosis factor receptor superfamily member 12A), or Tweak-receptor (TweakR). Receptor for TWEAK ligand.
CD267	Transmembrane activator and CAML interactor (TACI), or tumor necrosis factor receptor superfamily member 13B (TNFRSF13B); a transmembrane protein of the TNF receptor superfamily found predominantly on the surface of B cells, which are an important part of the immune system. TACI recognizes three ligands: APRIL (CD256), BAFF (CD257) and CAML. TACI controls T cell-independent B cell antibody responses, isotype switching and B cell homeostasis. TACI mutations are associated with immunodeficiency; a significant proportion of CVID patients have TACI mutations.
CD268	BAFF receptor (B-cell activating factor receptor, BAFF-R), or tumor necrosis factor receptor superfamily member 13C (TNFRSF13C). TNFRSF13C is a membrane protein of the TNF receptor superfamily which recognizes BAFF.
CD269	Also known as B-cell maturation antigen (BCMA or BCM) or tumor necrosis factor receptor superfamily member 17 (TNFRSF17). Protein encoded by the TNFRSF17 gene. This receptor is preferentially expressed in mature B lymphocytes, and may be connected to leukemias and lymphomas. BCMA is brightly expressed on most multiple myeloma cells and hence of interest as a target for CART therapy.^[55] Bluebird and Celgene currently have an anti-BCMA early-stage product, bb2121, due to start trials for multiple myeloma in 2016.^[56]
CD270	Herpesvirus entry mediator (HVEM), or tumor necrosis factor receptor superfamily member 14 (TNFRSF14); a human cell surface receptor of the TNF-receptor superfamily. Binding of HSV viral envelope glycoprotein D (gD) to CD270 shown to be part of viral entry mechanism. Interacts with TRAF2, TNFSF14 (CD258) and TRAF5. BTLA (CD272) is a ligand for HVEM.
CD271	is the p75 Nerve Growth factor receptor (NGFR) or Low-affinity Nerve Growth Factor Receptor (LNGFR) and a member of the tumor necrosis factor receptor (TNF receptor) superfamily. LNGFR has been implicated as a marker for cancer stem cells in melanoma and other cancers. Melanoma cells transplanted into an immunodeficient mouse model were shown to require expression of CD271 in order to grow a melanoma. Thus CD271 is under investigation as a cell marker for melanoma drugs (2016).^[57]
CD272	BTLA (B- and T-lymphocyte attenuator); expression induced during activation of T cells. Like PD1 and CTLA4, BTLA interacts with a B7 homolog, B7H4. However, unlike PD-1 (CD279) and CTLA-4 (CD152), BTLA displays T-Cell inhibition via interaction with tumor necrosis family receptors (TNF-R), not just the B7 family of cell surface receptors. BTLA is a ligand for HVEM (CD270). BTLA-HVEM complexes negatively regulate T-cell immune responses. BTLA activation inhibits the function of CD8+ cancer-specific T cells.
CD273	PDL2 or PDCD1LG2 (Programmed Cell Death 1 Ligand 2); on Dendritic cells, Macrophages etc. Ligand for PD-1 (CD279)
CD274	PDL1 or PDCD1L1 (Programmed Cell Death 1 Ligand 1); expressed on T cells, NK cells, macrophages, myeloid DCs, B cells, epithelial cells, and vascular endothelial cells and others. Ligand for PD1 (CD279) and also CD80 (B7-1). Formation of PD1/PDL1 or B7-1/PDL1 complexes transmit an inhibitory signal reducing proliferation of CD8+ T cells at lymph nodes. Anti-PDL1 drugs like Atezolizumab, currently in trials for bladder cancer, work by preventing the inhibition of T-cells.
CD275	ICOSLG or ICOS ligand.
CD276	CD276 (aka B7-H3), an immune checkpoint molecule, is expressed by some solid tumours and is the target of anticancer candidates such as Macrogenics' MGA271
CD277	aka Butyrophilin subfamily 3 member A1 (BTN3A1)
CD278	Inducible T-cell costimulator (ICOS) is an immune checkpoint protein; a CD28-superfamily costimulatory molecule expressed on activated T cells; thought to be important for Th2 cells. Used as a biomarker in Ipilimumab treatment.
CD279	PD-1 or PDCD1 (Programmed Cell Death 1); cell surface receptor which binds to PD-L1 and PD-L2 ligands; functions as immune checkpoint with important role in down regulating immune system by preventing T-cell activation. Targeted by Nivolumab, Pembrolizumab and other monoclonal antibodies in a new class of cancer drugs.
CD280	Mannose receptor C type 2 (MRC2)
CD281	TLR1; a member of the Toll-like receptor family (TLR) of pattern recognition receptors of the innate immune system. TLR1 recognizes pathogen-associated molecular pattern with a specificity for gram-positive bacteria; found on the surface of macrophages and neutrophils; interacts with TLR2 (CD282).
CD282	Toll-like receptor 2 (TLR2); plays a role in the immune system. TLR2 is a membrane protein, recognizing bacterial, fungal, viral, and certain endogenous substances and passing on appropriate signals to the cells of the immune system.
CD283	Toll-like receptor 3 (TLR3); abundantly expressed in placenta and pancreas, and restricted to the dendritic subpopulation of leukocytes. It recognizes dsRNA associated with viral infection, and induces activation of IRF3, unlike all other Toll-like receptors which activate NF-κB. IRF3 ultimately induces the production of type I interferons, and thus may play role in defense against viruses
CD284	Toll-like receptor 4 (TLR4 or TOLL). It detects lipopolysaccharide from Gram-negative bacteria and is thus important in the activation of the innate immune system. Various μ-opioid receptor ligands have been found to possess action as agonists or antagonists of TLR4, with opioid agonists such as morphine being TLR4 agonists.
CD285	not assigned
CD286	Toll-like receptor 6 (TLR6). This receptor functionally interacts with TLR2 (CD282) to mediate cellular response to bacterial lipoproteins.
CD287	not assigned
CD288	Toll-like receptor 8 (TLR8); Genetic variants in TLR8 have recently been linked to susceptibility to pulmonary tuberculosis.
CD289	Toll-like receptor 9 (TLR9). TLR9 recognizes unmethylated CpG sequences in DNA molecules. Biotech company Mologen is currently (2017) testing a TLR9 agonist, Lefitolimod, for treatment of HIV and various cancers.
CD290	Toll-like receptor 10 (TLR10); most highly expressed in lymphoid tissues such as spleen, lymph node, thymus, and tonsil
CD291	not assigned
CD292	Bone morphogenetic protein receptor, type IA (BMPR1A)
CDw293	Bone morphogenetic protein receptor type-1B (BMPR1B); Mutations in the associated gene have been linked with primary pulmonary hypertension.
CD294	Prostaglandin D2 receptor 2 (DP2) or GPR44; a human protein encoded by the PTGDR2 gene. The DP2 pathway has been suggested as a potential target for baldness treatment.
CD295	Leptin receptor (LEPR or OBR); LEPR functions as a receptor for the fat cell-specific hormone leptin. Variations in the leptin receptor have been associated with obesity and increased susceptibility to Entamoeba histolytica infections.
CD296	ADP-ribosyltransferase 1 (ART1 gene);^[58]^[59]
CD297	Ecto-ADP-ribosyltransferase 4 (ART4)
CD298	Sodium/potassium-transporting ATPase subunit beta-3 (ATP1B3);
CD299	C-type lectin domain family 4 member M (CLEC4M) or LSIGN (liver/lymph node-specific intracellular adhesion molecules-3 grabbing non-integrin);
CD300A	CMRF35H, present on monocytes, neutrophils, and some T and B lymphocytes
CD300C	CMRF35A
CD301	CLEC10A (C-type lectin domain family 10 member A). Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response.
CD302	CD302 is a C-type lectin receptor involved in cell adhesion and migration, as well as endocytosis and phagocytosis.
CD303	BDCA-2, a type II C-type lectin (CLEC4C) which is involved in endocytosis of antigens for processing in plasmacytoid dendritic cells. Activation decreases type I interferon production.
CD304	Neuropilin-1 (NP-1), NRP1 or BDCA-4, has a wide range of functions. On neurons, it is a receptor for axon growth guidance class-3 semaphorins SEMA3A and plexin-1, on endothelial and some tumor cells it is a VEGF₁₆₅ receptor, and on plasmacytoid dendritic cells it has a similar role to CD303 but does not decrease interferon production upon activation.
CD305	LAIR1, (Leukocyte-associated immunoglobulin-like receptor 1) is an inhibitory receptor found on peripheral mononuclear cells, including NK cells, T cells, and B cells. Inhibitory receptors regulate the immune response to prevent lysis of cells recognized as self.
CD306	LAIR2, (Leukocyte-associated immunoglobulin-like receptor 2) is a member of the immunoglobulin superfamily. The function of this protein is unknown, though it is thought to be secreted and may help modulate mucosal tolerance.
CD307	FCRL5, (Fc receptor-like protein 5)
CD307a	FCRL1, (Fc receptor-like protein 1)
CD307b	FCRL2, (Fc receptor-like protein 2)
CD307c	FCRL3, (Fc receptor-like protein 3)
CD307d	FCRL4, (Fc receptor-like protein 4)
CD307e	FCRL5, (Fc receptor-like protein 5)
CD308	not assigned
CD309	Kinase insert domain receptor, (KDR), a type III tyrosine kinase receptor involved in angiogenesis.
CD310	not assigned
CD311	not assigned
CD312	EMR2, (EGF-like module-containing mucin-like hormone receptor-like 2) is a protein encoded by the ADGRE2 gene. EMR2, a member of the adhesion GPCR family, is expressed by monocytes/macrophages, dendritic cells and all types of granulocytes and is closely related to CD97.
CD313	not assigned
CD314	KLRK1 or NKG2D is a transmembrane protein belonging to the CD94/NKG2 family of C-type lectin-like receptors. NKG2D is encoded by KLRK1 gene in the NK-gene complex (NKC) on chromosome 12 in humans. In humans it is expressed by NK cells, γδ T cells and CD8+ αβ T cells. NKG2D recognizes induced-self proteins from MIC and RAET1/ULBP families which appear on the surface of stressed, malignant transformed, and infected cells. Thought important in viral control as some viruses have adapted mechanisms to evade NKG2D responses. Also, tumor cells that can evade NKG2D responses are more likely to propagate.
CD315	PTGFRN, (Prostaglandin F2 receptor negative regulator), found to interact with CD9 and CD81
CD316	IGSF8, (Immunoglobulin superfamily member 8)
CD317	Tetherin or BST2 (bone marrow stromal antigen 2), is a lipid raft associated protein. Expressed in mature B cells, plasma cells, plasmacytoid dendritic cells, and many other cells, only as a response to stimuli from IFN pathway. Known to block many types of enveloped viruses by tethering the budding virus like particles (VLPs) and inhibiting them from leaving the cell surface.
CD318	CDCP1, (CUB domain-containing protein 1) and Trask (Transmembrane and associated with src kinases). The phosphorylation of CDCP1 is seen in many cancers, including some pre-invasive cancers as well as in invasive tumors and in tumor metastases. The functional implications of CDCP1 phosphorylation in tumors is currently under investigation.
CD319	SLAMF7, a marker of normal plasma cells and malignant plasma cells in multiple myeloma.
CD320	8D6A
CD321	F11R (F11 Receptor), or JAM1 (Junctional adhesion molecule A)
CD322	JAM2 (Junctional adhesion molecule B). Acts as an adhesive ligand for interacting with a variety of immune cell types and may play a role in lymphocyte homing to secondary lymphoid organs.
CD323	not assigned
CD324	A tumor-suppressor gene encoded by the CDH1 (gene) gene also known as Cadherin-1, CAM 120/80, epithelial cadherin (E-cadherin) or uvomorulin. Mutations (loss) in this gene are correlated with gastric, breast, colorectal, thyroid, and ovarian cancers.
CD325	CDH2, Cadherin-2, N-cadherin or neural cadherin (NCAD). It is a transmembrane protein expressed in multiple tissues and functions to mediate cell-cell adhesion. In cardiac muscle, N-cadherin is an integral component in adherens junctions residing at intercalated discs, which function to mechanically and electrically couple adjacent cardiomyocytes. Alterations in expression and integrity of N-cadherin protein has been observed in various forms of disease, including human dilated cardiomyopathy.
CD326	Epithelial cell adhesion molecule (EpCAM) or Tumor-associated calcium signal transducer 1 (TACSTD1). Expressed on epithelial cells and on many tumors; used as a target for anti-tumor drugs. CD326 is expressed in pluripotent stem cells.
CD327	SIGLEC6, (Sialic acid-binding Ig-like lectin 6)
CD328	SIGLEC7, (Sialic acid-binding Ig-like lectin 7)
CD329	SIGLEC9, (Sialic acid-binding Ig-like lectin 9)
CD330	not assigned
CD331	FGFR1 (Fibroblast growth factor receptor 1). A receptor tyrosine kinase whose ligands are specific members of the fibroblast growth factor family. FGFR1 has been shown to be associated with Pfeiffer syndrome. Mutations in the associated gene have also been associated Jackson–Weiss syndrome, Antley-Bixler syndrome, Trigonocephaly, osteoglophonic dysplasia, squamous cell lung cancer and autosomal dominant Kallmann syndrome and may be associated with cleft lip and/or palate. Somatic mutations of the FGFR1 gene occurs in several diseases including breast and lung cancers. Experimental drug Lucitanib from Clovis targets FGFR1, which is over-expressed on some tumor cells causing increased proliferation.
CD332	FGFR2 (Fibroblast growth factor receptor 2). FGFR2 has important roles in embryonic development and tissue repair, especially bone and blood vessels. Mutations are associated with numerous medical conditions including abnormal bone development (e.g. craniosynostosis syndromes) and cancer. Five Prime has a monoclonal antibody, FPA144, in early stage trials, that targets FGFR2b (a form of FGFR2), to treat gastric tumours that overexpress FGFR2b, by preventing binding of certain FGFs to FGFR2b.
CD333	FGFR3 (Fibroblast growth factor receptor 3). Defects in the FGFR3 gene have been associated with several conditions, including achondroplasia/hypochondroplasia, thanatophoric dwarfism, seborrheic keratosis, bladder cancer and craniosynostosis
CD334	FGFR4 (Fibroblast growth factor receptor 4). Although specific function is unknown, overexpressed in gynecological tumor samples, suggesting a role in breast and ovarian tumorigenesis.
CD335	Also known as NCR1 or NKp46
CD336	NCR2 (Natural cytotoxicity triggering receptor 2)
CD337	Also known as Natural cytotoxicity triggering receptor 3 NCR3 or NKp30. Protein that in humans is encoded by the NCR3 gene.
CD338	ABCG2 (ATP-binding cassette sub-family G member 2) or BCRP (Breast Cancer Resistance Protein). This protein functions as a xenobiotic transporter which may play a role in multi-drug resistance to chemotherapeutic agents. Significant expression observed in placenta, and role protecting fetus from xenobiotics in maternal circulation. Also protective roles in blocking absorption at the apical membrane of the intestine, blood-testis barrier, blood–brain barrier, and membranes of hematopoietic progenitor and other stem cells. At apical membranes of liver and kidney, enhances excretion of xenobiotics. In lactating mammary gland, role in excreting vitamins such as riboflavin and biotin into milk.
CD339	JAG1 (Jagged 1). One of five cell surface proteins (ligands) that interact with 4 receptors in the mammalian Notch signaling pathway. The JAG1 gene is expressed in multiple organ systems in the body and causes the autosomal dominant disorder Alagille syndrome (ALGS) resulting from loss of function mutations within the gene. Up regulation of JAG1 has been correlated with both poor overall breast cancer survival rates and an enhancement of tumor proliferation in adrenocortical carcinoma patients
CD340	Receptor tyrosine-protein kinase erbB-2, HER2 (human epidermal growth factor receptor 2) or HER2/neu. Overexpression plays a role in certain types of breast cancer. It is a biomarker target for breast cancer drugs such as Herceptin.
CD344	FZD4 (Frizzled-4) a receptor in WNT-signalling pathway and for Norrin. FZD4 signaling induced by Norrin regulates vascular development of vertebrate retina and controls important blood vessels in the ear.
CD349	FZD9 (Frizzled-9) a receptor in WNT-signalling pathway. The FZD9 gene is located within the Williams syndrome common deletion region of chromosome 7, and heterozygous deletion of the FZD9 gene may contribute to the Williams syndrome phenotype. FZD9 is expressed predominantly in brain, testis, eye, skeletal muscle, and kidney
CD351	FCAMR, (Fcα/μR), an Fc receptor that binds IgM with high affinity and IgA with a 10-fold lower affinity.
CD352	SLAMF6, (Signaling lymphocytic activation molecule family member 6), expressed on Natural killer (NK), T, and B lymphocytes.
CD353	SLAMF8, (Signaling lymphocytic activation molecule family member 8), expressed in lymphoid tissues.
CD354	TREM1, Triggering receptor expressed on myeloid cells 1.
CD355	Cytotoxic and regulatory T-cell molecule, encoded by CRTAM gene. Strongly expressed in spleen, thymus, small intestine, peripheral blood leukocyte and in Purkinje neurons in cerebellum.
CD357	TNFRSF18, Tumor necrosis factor receptor superfamily member 18, activation-inducible TNFR family receptor (AITR) or Glucocorticoid-induced TNFR-related protein (GITR). This receptor has increased expression upon T-cell activation, and is thought to play a key role in dominant immunological self-tolerance maintained by CD25+/CD4+ regulatory T cells. There are several anti-GITR agonist antibodies in early-stage development. Activating the GITR receptor is thought to increase the proliferation and function of effector T cells, particularly in combination with anti-PDL1 antibodies. As of 2015, TG Therapeutics and Five Prime / Inhibrx have clinical stage antibodies; Merck (MK4166), Medimmune AstraZeneca (MEDI1873), and the company GITR (TRX518) have antibodies in phase 1 trials for solid tumors. In 2016, Novartis initiated an anti-GITR (GWN323) trial.^[60]
CD358	Death receptor 6 (DR6) or tumor necrosis factor receptor superfamily member 21 (TNFRSF21), it activates the JNK and NF-κB pathways and is mostly expressed in the thymus, spleen and white blood cells.
CD360	IL21R (Interleukin 21 receptor). It is a cytokine receptor for interleukin 21 (IL21). It transduces the growth promoting signal of IL21, and is important for the proliferation and differentiation of T cells, B cells, and natural killer (NK) cells. The ligand binding of this receptor leads to the activation of multiple downstream signaling molecules, including JAK1, JAK3, STAT1, and STAT3.
CD361	Also known as EVI2B.
CD362	Also known as SDC2, Syndecan-2.
CD363	S1PR1 (Sphingosine-1-phosphate receptor 1) or EDG1. It is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 activation is involved in immune cell regulation and development; vascular growth and development during embryogenesis; motility of cancer cells; it is also over-expressed in MS lesions. Receptos Celgene has a drug in development, Ozanimod, which modulates S1P1R1 in the treatment of immune-inflammatory diseases MS and ulcerative colitis. It is believed to work by interfering with S1P signaling, blocking the lymphocyte response to lymph node exit signals by sequestering them within the nodes, and thus reducing circulating lymphocytes and anti-inflammatory activity by inhibiting cell migration to sites of inflammation.
CD364	Peptidase inhibitor 16, or Cysteine-rich secretory protein 9 (CRISP-9) encoded by PI16 gene
CD365	HAVCR1 (Hepatitis A virus cellular receptor 1) or TIM-1 (T-cell immunoglobulin and mucin domain 1). Plays critical roles in regulating immune cell activity especially in response to viral infection including HAV, Ebola and Dengue. TIM-1 is also involved in allergic response, asthma, and transplant tolerance.
CD366	Also known as HAVCR2 (Hepatitis A virus cellular receptor 2) or TIM-3 (T-cell immunoglobulin and mucin domain 3). TIM3 is under investigation as a cancer immune checkpoint target as it may function as a T cell inhibitory receptor and is expressed on CD8+ T cells and Tregs, both involved in immunosuppression. Enumeral / Merck is studying a co-blockade of PD1 and TIM3 pathways; Novartis is also testing an anti-TIM3 therapy with MBG453 (2015).
CD367	Also known as CLEC4A. C-type lectin domain family 4 member A.
CD368	Also known as CLEC4D.
CD369	Also known as CLEC7A. C-type lectin domain family 7 member A or Dectin-1
CD370	Also known as CLEC9A.
CD371	Also known as CLEC12A, C-type lectin domain family 12 member A.^[61]

References

^ Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature. 1989, 341 (6241): 447–50. Bibcode:1989Natur.341..447P. PMID 2477705. S2CID 4264602. doi:10.1038/341447a0.
^ Sköld M, Behar SM. The role of group 1 and group 2 CD1-restricted T cells in microbial immunity. Microbes Infect. 2005, 7 (3): 544–51. PMID 15777730. doi:10.1016/j.micinf.2004.12.012.
^ Gras S, Van Rhijn I, Shahine A, Cheng TY, Bhati M, Tan LL, et al. T cell receptor recognition of CD1b presenting a mycobacterial glycolipid. Nature Communications. October 2016, 7: 13257. Bibcode:2016NatCo...713257G. PMC 5095289 . PMID 27807341. doi:10.1038/ncomms13257.
^ P15813 (CD1D_HUMAN). Uniprot. [1 March 2013].
^ Weissman AM, Hou D, Orloff DG, Modi WS, Seuanez H, O'Brien SJ, Klausner RD. Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain: distinction from the molecular CD3 complex. Proc. Natl. Acad. Sci. U.S.A. December 1988, 85 (24): 9709–13. Bibcode:1988PNAS...85.9709W. PMC 282845 . PMID 2974162. doi:10.1073/pnas.85.24.9709 .
^ Zamani M, Tabatabaiefar MA, Mosayyebi S, Mashaghi A, Mansouri P. Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population. Clinical and Experimental Dermatology. July 2010, 35 (5): 521–4. PMID 19843086. S2CID 10427963. doi:10.1111/j.1365-2230.2009.03667.x.
^ Entrez Gene: CD5 CD5 molecule.
^ Brown MH, Lacey E. A ligand for CD5 is CD5. Journal of Immunology. Nov 15, 2010, 185 (10): 6068–74. PMC 2996635 . PMID 20952682. doi:10.4049/jimmunol.0903823.
^ ^9.0 ^9.1 Leong, Anthony S-Y; Cooper, Kumarason; Leong, F Joel W-M. Manual of Diagnostic Cytology 2. Greenwich Medical Media, Ltd. 2003: 67–68. ISBN 1-84110-100-1.
^ De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, Baranzini SE, McCauley JL, Pericak-Vance MA, Haines JL, Gibson RA, Naeglin Y, Uitdehaag B, Matthews PM, Kappos L, Polman C, McArdle WL, Strachan DP, Evans D, Cross AH, Daly MJ, Compston A, Sawcer SJ, Weiner HL, Hauser SL, Hafler DA, Oksenberg JR. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 2009, 41 (7): 776–82. PMC 2757648 . PMID 19525953. doi:10.1038/ng.401.
^ Kofler DM, Severson CA, Mousissian N, De Jager PL, Hafler DA. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation. J. Immunol. 2011, 187 (6): 3286–91. PMID 21849685. doi:10.4049/jimmunol.1100626 .
^ Entrez Gene: CD7 CD7 molecule.
^ Entrez Gene: CD8A CD8a molecule.
^ Gao GF, Willcox BE, Wyer JR, Boulter JM, O'Callaghan CA, Maenaka K, Stuart DI, Jones EY, Van Der Merwe PA, Bell JI, Jakobsen BK. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J. Biol. Chem. May 2000, 275 (20): 15232–8. PMID 10809759. doi:10.1074/jbc.275.20.15232 .
^ ^15.0 ^15.1 Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, Stuart DI, Bell JI, Jones EY, Jakobsen BK. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature. June 1997, 387 (6633): 630–4. Bibcode:1997Natur.387..630G. PMID 9177355. S2CID 4267617. doi:10.1038/42523.
^ Doucey MA, Goffin L, Naeher D, Michielin O, Baumgärtner P, Guillaume P, Palmer E, Luescher IF. CD3 delta establishes a functional link between the T cell receptor and CD8. J. Biol. Chem. January 2003, 278 (5): 3257–64. PMID 12215456. doi:10.1074/jbc.M208119200 .
^ Sanders SK, Giblin PA, Kavathas P. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts. J. Exp. Med. September 1991, 174 (3): 737–40. PMC 2118947 . PMID 1908512. doi:10.1084/jem.174.3.737.
^ Andreu Z, Yáñez-Mó M. Tetraspanins in extracellular vesicle formation and function. Frontiers in Immunology. 2014, 8: 342. PMC 4165315 . PMID 25278937. doi:10.3389/fimmu.2014.00442 .
^ CD9 CD9 molecule [Homo sapiens (human)] - Gene - NCBI. www.ncbi.nlm.nih.gov. [2019-12-04].
^ CD9 Gene - GeneCards | CD9 Protein | CD9 Antibody. www.genecards.org. [2019-12-04].
^ Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M, Sánchez-Madrid F. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends in Cell Biology. September 2009, 19 (9): 434–46. PMID 19709882. doi:10.1016/j.tcb.2009.06.004.
^ Yang XH, Kovalenko OV, Kolesnikova TV, Andzelm MM, Rubinstein E, Strominger JL, Hemler ME. Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization. The Journal of Biological Chemistry. May 2006, 281 (18): 12976–85. PMID 16537545. doi:10.1074/jbc.M510617200 .
^ Hemler ME. Tetraspanin functions and associated microdomains. Nature Reviews. Molecular Cell Biology. October 2005, 6 (10): 801–11. PMID 16314869. S2CID 5906694. doi:10.1038/nrm1736.
^ Machado-Pineda Y, Cardeñes B, Reyes R, López-Martín S, Toribio V, Sánchez-Organero P, et al. CD9 Controls Integrin α5β1-Mediated Cell Adhesion by Modulating Its Association With the Metalloproteinase ADAM17. Frontiers in Immunology. 2018, 9: 2474. PMC 6230984 . PMID 30455686. doi:10.3389/fimmu.2018.02474 .
^ Rubinstein E, Billard M, Plaisance S, Prenant M, Boucheix C. Molecular cloning of the mouse equivalent of CD9 antigen. Thrombosis Research. September 1993, 71 (5): 377–83. PMID 8236164. doi:10.1016/0049-3848(93)90162-h.
^ Ventress JK, Partridge LJ, Read RC, Cozens D, MacNeil S, Monk PN. Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes. PLOS ONE. 2016-07-28, 11 (7): e0160387. Bibcode:2016PLoSO..1160387V. PMC 4965146 . PMID 27467693. doi:10.1371/journal.pone.0160387 .
^ Blake DJ, Martiszus JD, Lone TH, Fenster SD. Ablation of the CD9 receptor in human lung cancer cells using CRISPR/Cas alters migration to chemoattractants including IL-16. Cytokine. November 2018, 111: 567–570. PMID 29884309. S2CID 46997236. doi:10.1016/j.cyto.2018.05.038.
^ Miki Y, Yashiro M, Okuno T, Kitayama K, Masuda G, Hirakawa K, Ohira M. CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells. British Journal of Cancer. March 2018, 118 (6): 867–877. PMC 5886122 . PMID 29438363. doi:10.1038/bjc.2017.487.
^ Lin Q, Peng S, Yang Y. Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H. International Journal of Oncology. July 2018, 53 (1): 266–274. PMID 29749468. doi:10.3892/ijo.2018.4381 .
^ Liang P, Miao M, Liu Z, Wang H, Jiang W, Ma S, et al. CD9 expression indicates a poor outcome in acute lymphoblastic leukemia. Cancer Biomarkers. 2018, 21 (4): 781–786. PMID 29286918. doi:10.3233/CBM-170422.
^ Zöller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nature Reviews. Cancer. January 2009, 9 (1): 40–55. PMID 19078974. S2CID 32065330. doi:10.1038/nrc2543.
^ Galy, Anne; Travis, Marilyn; Cen, Dazhi; Chen, Benjamin. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset.. Immunity. Oct 1995, 3 (4): 459–73. PMID 7584137. doi:10.1016/1074-7613(95)90175-2 .
^ Entrez Gene: ITGAL integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide).
^ Lu C, Amin MA, Fox DA. CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders.. J Immunol. 2020, 204 (1): 3–11. PMC 6997018 . PMID 31848300. doi:10.4049/jimmunol.1900868.
^ Setoguchi M, Nasu N, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S. Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. July 1989, 1008 (2): 213–22. PMID 2472171. doi:10.1016/0167-4781(80)90012-3.
^ Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood. January 1989, 73 (1): 284–9. PMID 2462937. doi:10.1182/blood.V73.1.284.284 .
^ Kerr MA, Stocks SC. The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion. Histochem. J. November 1992, 24 (11): 811–26. PMID 1362195. S2CID 8602651. doi:10.1007/BF01046353.
^ ^38.0 ^38.1 Bennett JS. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005; 115:3363-9.
^ FITC Anti-human CD51 Antibody Anti-CD51 - NKI-M9 - BioLegend.
^ Cassier, Philippe A.; Italiano, Antoine; Gomez-Roca, Carlos A.; Le Tourneau, Christophe; Toulmonde, Maud; Cannarile, Michael A.; Ries, Carola; Brillouet, Anne; Müller, Claudia; Jegg, Anna-Maria; Bröske, Ann-Marie; Dembowski, Markus; Bray-French, Katharine; Freilinger, Christine; Meneses-Lorente, Georgina; Baehner, Monika; Harding, Ross; Ratnayake, Jayantha; Abiraj, Keelara; Gass, Nathalie; Noh, Karen; Christen, Randolph D.; Ukarma, Lidia; Bompas, Emmanuelle; Delord, Jean-Pierre; Blay, Jean-Yves; Rüttinger, Dominik. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: A dose-escalation and dose-expansion phase 1 study. The Lancet Oncology. 2015, 16 (8): 949–956. PMID 26179200. doi:10.1016/S1470-2045(15)00132-1.
^ https://www.regeneron.com/sites/default/files/Dupixent_FPI.pdf ^[裸網址]
^ http://www.pieris.com/pipeline/respiratory-anemia-and-other-disease-areas/prs-060^{[永久失效連結]}
^ PRS-343 :: Pieris Pharmaceuticals, Inc. (PIRS). [2016-09-28]. （原始内容存档于2016-10-02）.
^ Lilly Oncology Pipeline | Lilly USA.
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-13].
^ IL10RA - Interleukin-10 receptor subunit alpha precursor - Homo sapiens (Human). www.uniprot.org. [2015-10-13].
^ IL10RB - Interleukin-10 receptor subunit beta precursor - Homo sapiens (Human). www.uniprot.org. [2015-10-13].
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-13].
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-13].
^ Clinical trial number NCT02215967 for "Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma" at ClinicalTrials.gov
^ Celgene narrows pioneering CAR-T collaboration with bluebird bio, hands over $25M sweetener. FierceBiotech. [2015-10-28].
^ UCI scientists identify a new approach for treating skin cancer.
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-12].
^ ART1 - GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 precursor - Homo sapiens (Human). www.uniprot.org. [2015-10-13].
^ Clinical trial number NCT02740270 for "Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas" at ClinicalTrials.gov
^ hcdm, Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-11]. ^{[永久失效連結]}

External links

AbCam antigen poster

[pmid2477705-1] Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature. 1989, 341 (6241): 447–50. Bibcode:1989Natur.341..447P. PMID 2477705. S2CID 4264602. doi:10.1038/341447a0.

[pmid15777730-2] Sköld M, Behar SM. The role of group 1 and group 2 CD1-restricted T cells in microbial immunity. Microbes Infect. 2005, 7 (3): 544–51. PMID 15777730. doi:10.1016/j.micinf.2004.12.012.

[3] Gras S, Van Rhijn I, Shahine A, Cheng TY, Bhati M, Tan LL, et al. T cell receptor recognition of CD1b presenting a mycobacterial glycolipid. Nature Communications. October 2016, 7: 13257. Bibcode:2016NatCo...713257G. PMC 5095289 . PMID 27807341. doi:10.1038/ncomms13257.

[P15813_CD1D_HUMAN-4] P15813 (CD1D_HUMAN). Uniprot. [1 March 2013].

[pmid2974162-5] Weissman AM, Hou D, Orloff DG, Modi WS, Seuanez H, O'Brien SJ, Klausner RD. Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain: distinction from the molecular CD3 complex. Proc. Natl. Acad. Sci. U.S.A. December 1988, 85 (24): 9709–13. Bibcode:1988PNAS...85.9709W. PMC 282845 . PMID 2974162. doi:10.1073/pnas.85.24.9709 .

[pmid19843086-6] Zamani M, Tabatabaiefar MA, Mosayyebi S, Mashaghi A, Mansouri P. Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population. Clinical and Experimental Dermatology. July 2010, 35 (5): 521–4. PMID 19843086. S2CID 10427963. doi:10.1111/j.1365-2230.2009.03667.x.

[entrez5-7] Entrez Gene: CD5 CD5 molecule.

[8] Brown MH, Lacey E. A ligand for CD5 is CD5. Journal of Immunology. Nov 15, 2010, 185 (10): 6068–74. PMC 2996635 . PMID 20952682. doi:10.4049/jimmunol.0903823.

[Leong-9] 9.0 ^9.1 Leong, Anthony S-Y; Cooper, Kumarason; Leong, F Joel W-M. Manual of Diagnostic Cytology 2. Greenwich Medical Media, Ltd. 2003: 67–68. ISBN 1-84110-100-1.

[pmid19525953-10] De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, Baranzini SE, McCauley JL, Pericak-Vance MA, Haines JL, Gibson RA, Naeglin Y, Uitdehaag B, Matthews PM, Kappos L, Polman C, McArdle WL, Strachan DP, Evans D, Cross AH, Daly MJ, Compston A, Sawcer SJ, Weiner HL, Hauser SL, Hafler DA, Oksenberg JR. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 2009, 41 (7): 776–82. PMC 2757648 . PMID 19525953. doi:10.1038/ng.401.

[pmid21849685-11] Kofler DM, Severson CA, Mousissian N, De Jager PL, Hafler DA. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation. J. Immunol. 2011, 187 (6): 3286–91. PMID 21849685. doi:10.4049/jimmunol.1100626 .

[entrez7-12] Entrez Gene: CD7 CD7 molecule.

[entrez8-13] Entrez Gene: CD8A CD8a molecule.

[pmid10809759-14] Gao GF, Willcox BE, Wyer JR, Boulter JM, O'Callaghan CA, Maenaka K, Stuart DI, Jones EY, Van Der Merwe PA, Bell JI, Jakobsen BK. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J. Biol. Chem. May 2000, 275 (20): 15232–8. PMID 10809759. doi:10.1074/jbc.275.20.15232 .

[pmid9177355-15] 15.0 ^15.1 Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, Stuart DI, Bell JI, Jones EY, Jakobsen BK. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature. June 1997, 387 (6633): 630–4. Bibcode:1997Natur.387..630G. PMID 9177355. S2CID 4267617. doi:10.1038/42523.

[pmid12215456-16] Doucey MA, Goffin L, Naeher D, Michielin O, Baumgärtner P, Guillaume P, Palmer E, Luescher IF. CD3 delta establishes a functional link between the T cell receptor and CD8. J. Biol. Chem. January 2003, 278 (5): 3257–64. PMID 12215456. doi:10.1074/jbc.M208119200 .

[pmid1908512-17] Sanders SK, Giblin PA, Kavathas P. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts. J. Exp. Med. September 1991, 174 (3): 737–40. PMC 2118947 . PMID 1908512. doi:10.1084/jem.174.3.737.

[Andreu_2014-18] Andreu Z, Yáñez-Mó M. Tetraspanins in extracellular vesicle formation and function. Frontiers in Immunology. 2014, 8: 342. PMC 4165315 . PMID 25278937. doi:10.3389/fimmu.2014.00442 .

[19] CD9 CD9 molecule [Homo sapiens (human)] - Gene - NCBI. www.ncbi.nlm.nih.gov. [2019-12-04].

[20] CD9 Gene - GeneCards | CD9 Protein | CD9 Antibody. www.genecards.org. [2019-12-04].

[Yáñez-Mó_2009-21] Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M, Sánchez-Madrid F. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends in Cell Biology. September 2009, 19 (9): 434–46. PMID 19709882. doi:10.1016/j.tcb.2009.06.004.

[Yang_2006-22] Yang XH, Kovalenko OV, Kolesnikova TV, Andzelm MM, Rubinstein E, Strominger JL, Hemler ME. Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization. The Journal of Biological Chemistry. May 2006, 281 (18): 12976–85. PMID 16537545. doi:10.1074/jbc.M510617200 .

[Hemler_2005-23] Hemler ME. Tetraspanin functions and associated microdomains. Nature Reviews. Molecular Cell Biology. October 2005, 6 (10): 801–11. PMID 16314869. S2CID 5906694. doi:10.1038/nrm1736.

[24] Machado-Pineda Y, Cardeñes B, Reyes R, López-Martín S, Toribio V, Sánchez-Organero P, et al. CD9 Controls Integrin α5β1-Mediated Cell Adhesion by Modulating Its Association With the Metalloproteinase ADAM17. Frontiers in Immunology. 2018, 9: 2474. PMC 6230984 . PMID 30455686. doi:10.3389/fimmu.2018.02474 .

[25] Rubinstein E, Billard M, Plaisance S, Prenant M, Boucheix C. Molecular cloning of the mouse equivalent of CD9 antigen. Thrombosis Research. September 1993, 71 (5): 377–83. PMID 8236164. doi:10.1016/0049-3848(93)90162-h.

[26] Ventress JK, Partridge LJ, Read RC, Cozens D, MacNeil S, Monk PN. Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes. PLOS ONE. 2016-07-28, 11 (7): e0160387. Bibcode:2016PLoSO..1160387V. PMC 4965146 . PMID 27467693. doi:10.1371/journal.pone.0160387 .

[Blake_2018-27] Blake DJ, Martiszus JD, Lone TH, Fenster SD. Ablation of the CD9 receptor in human lung cancer cells using CRISPR/Cas alters migration to chemoattractants including IL-16. Cytokine. November 2018, 111: 567–570. PMID 29884309. S2CID 46997236. doi:10.1016/j.cyto.2018.05.038.

[Miki_2018-28] Miki Y, Yashiro M, Okuno T, Kitayama K, Masuda G, Hirakawa K, Ohira M. CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells. British Journal of Cancer. March 2018, 118 (6): 867–877. PMC 5886122 . PMID 29438363. doi:10.1038/bjc.2017.487.

[29] Lin Q, Peng S, Yang Y. Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H. International Journal of Oncology. July 2018, 53 (1): 266–274. PMID 29749468. doi:10.3892/ijo.2018.4381 .

[30] Liang P, Miao M, Liu Z, Wang H, Jiang W, Ma S, et al. CD9 expression indicates a poor outcome in acute lymphoblastic leukemia. Cancer Biomarkers. 2018, 21 (4): 781–786. PMID 29286918. doi:10.3233/CBM-170422.

[31] Zöller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nature Reviews. Cancer. January 2009, 9 (1): 40–55. PMID 19078974. S2CID 32065330. doi:10.1038/nrc2543.

[32] Galy, Anne; Travis, Marilyn; Cen, Dazhi; Chen, Benjamin. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset.. Immunity. Oct 1995, 3 (4): 459–73. PMID 7584137. doi:10.1016/1074-7613(95)90175-2 .

[33] Entrez Gene: ITGAL integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide).

[pmid31848300-34] Lu C, Amin MA, Fox DA. CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders.. J Immunol. 2020, 204 (1): 3–11. PMC 6997018 . PMID 31848300. doi:10.4049/jimmunol.1900868.

[pmid2472171-35] Setoguchi M, Nasu N, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S. Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. July 1989, 1008 (2): 213–22. PMID 2472171. doi:10.1016/0167-4781(80)90012-3.

[pmid2462937-36] Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood. January 1989, 73 (1): 284–9. PMID 2462937. doi:10.1182/blood.V73.1.284.284 .

[pmid1362195-37] Kerr MA, Stocks SC. The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion. Histochem. J. November 1992, 24 (11): 811–26. PMID 1362195. S2CID 8602651. doi:10.1007/BF01046353.

[Bennett-38] 38.0 ^38.1 Bennett JS. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005; 115:3363-9.

[39] FITC Anti-human CD51 Antibody Anti-CD51 - NKI-M9 - BioLegend.

[40] Cassier, Philippe A.; Italiano, Antoine; Gomez-Roca, Carlos A.; Le Tourneau, Christophe; Toulmonde, Maud; Cannarile, Michael A.; Ries, Carola; Brillouet, Anne; Müller, Claudia; Jegg, Anna-Maria; Bröske, Ann-Marie; Dembowski, Markus; Bray-French, Katharine; Freilinger, Christine; Meneses-Lorente, Georgina; Baehner, Monika; Harding, Ross; Ratnayake, Jayantha; Abiraj, Keelara; Gass, Nathalie; Noh, Karen; Christen, Randolph D.; Ukarma, Lidia; Bompas, Emmanuelle; Delord, Jean-Pierre; Blay, Jean-Yves; Rüttinger, Dominik. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: A dose-escalation and dose-expansion phase 1 study. The Lancet Oncology. 2015, 16 (8): 949–956. PMID 26179200. doi:10.1016/S1470-2045(15)00132-1.

[41] ttps://www.regeneron.com/sites/default/files/Dupixent_FPI.pdf ^[裸網址]

[42] ttp://www.pieris.com/pipeline/respiratory-anemia-and-other-disease-areas/prs-060^{[永久失效連結]}

[43] PRS-343 :: Pieris Pharmaceuticals, Inc. (PIRS). [2016-09-28]. （原始内容存档于2016-10-02）.

[44] Lilly Oncology Pipeline | Lilly USA.

[45] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].

[46] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].

[47] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].

[48] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].

[49] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-15].

[50] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-13].

[51] IL10RA - Interleukin-10 receptor subunit alpha precursor - Homo sapiens (Human). www.uniprot.org. [2015-10-13].

[52] IL10RB - Interleukin-10 receptor subunit beta precursor - Homo sapiens (Human). www.uniprot.org. [2015-10-13].

[53] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-13].

[54] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-13].

[55] Clinical trial number NCT02215967 for "Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma" at ClinicalTrials.gov

[56] Celgene narrows pioneering CAR-T collaboration with bluebird bio, hands over $25M sweetener. FierceBiotech. [2015-10-28].

[57] UCI scientists identify a new approach for treating skin cancer.

[58] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-12].

[59] ART1 - GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 precursor - Homo sapiens (Human). www.uniprot.org. [2015-10-13].

[60] Clinical trial number NCT02740270 for "Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas" at ClinicalTrials.gov

[61] , Human Cell Differentiation Molecules. www.hcdm.org. [2015-10-11]. ^{[永久失效連結]}

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

[31]

[32]

[33]

[34]

[35]

[36]

[37]

[38]

[39]

[40]

[41]

[42]

[43]

[44]

[45]

[46]

[47]

[48]

[49]

[50]

[51]

[52]

[53]

[54]

[55]

[56]

[57]

[58]

[59]

[60]

[61]

查论编蛋白質：分化群（參見人類細胞分化群列表（英语：list of human clusters of differentiation））
1-50	CD1 a-c（英语：Group 1 CD1） 1A 1D（英语：CD1D） 1E（英语：CD1E） CD2 CD3（英语：CD3 (immunology)） γ（英语：CD3G） δ（英语：CD3D） ε（英语：CD3E） CD4 CD5（英语：CD5 (protein)） CD6 CD7 CD8 α（英语：CD8A） β CD9 CD10（英语：Neprilysin） CD11 a（英语：CD11a） b（英语：Integrin alpha M） c（英语：CD11c） d（英语：ITGAD） CD13 CD14 CD15（英语：CD15） CD16 A（英语：FCGR3A） B（英语：FCGR3B） CD18 CD19 CD20（英语：CD20） CD21（英语：Complement receptor 2） CD22 CD23（英语：CD23） CD24 CD25（英语：CD25） CD26 CD27（英语：CD27） CD28（英语：CD28） CD29 CD30（英语：CD30） CD31 CD32（英语：CD32） A（英语：FCGR2A） B（英语：FCGR2B） CD33 CD34 CD35（英语：Complement receptor 1） CD36（英语：CD36） CD37（英语：CD37） CD38（英语：CD38） CD39（英语：ENTPD1） CD40 CD41（英语：ITGA2B） CD42（英语：Glycoprotein Ib） a（英语：Glycoprotein IX） b（英语：GP1BA） c（英语：GP1BB） d（英语：GP5） CD43 CD44 CD45 CD46（英语：CD46） CD47 CD48（英语：CD48） CD49 a（英语：CD49a） b（英语：CD49b） c（英语：CD49c） d（英语：CD49d） e（英语：ITGA5） f（英语：ITGA6） CD50（英语：ICAM3）
51-100	CD51（英语：ITGAV） CD52（英语：CD52） CD53（英语：CD53） CD54（英语：ICAM-1） CD55 CD56 CD57（英语：B3GAT1） CD58（英语：CD58） CD59 CD61 CD62 E L P CD63 CD64（英语：CD64 (biology)） A（英语：FCGR1A） B（英语：FCGR1B） C（英语：FCGR1C） CD66 a（英语：CEACAM1） b c（英语：CEACAM6） d（英语：CEACAM3） e（英语：CEACAM5） f（英语：PSG1 (gene)） CD68（英语：CD68） CD69（英语：CD69） CD70（英语：CD70） CD71 CD72（英语：CD72） CD73（英语：NT5E） CD74（英语：CD74） CD78（英语：CD78） CD79 a（英语：CD79A） b（英语：CD79B） CD80 CD81（英语：CD81） CD82（英语：CD82 (gene)） CD83（英语：CD83） CD84（英语：CD84） CD85 a（英语：LILRB3） d（英语：LILRB2） e（英语：LILRA3） h（英语：LILRA2） j（英语：LILRB1） k（英语：LILRB4） CD86 CD87 CD88 CD89（英语：FCAR） CD90 CD91（英语：LRP1） -CD92（英语：SLC44A1） CD93（英语：CD93） CD94（英语：KLRD1） CD95（英语：Fas receptor） CD96（英语：CD96） CD97（英语：CD97） CD98（英语：CD98） CD99（英语：CD99） CD100（英语：SEMA4D）
101-150	CD101（英语：IGSF2） CD102（英语：ICAM2） CD103（英语：ITGAE） CD104（英语：ITGB4） CD105（英语：Endoglin） CD106 CD107 a（英语：LAMP1） b（英语：LAMP2） CD108（英语：SEMA7A） CD109（英语：CD109） CD110（英语：Myeloproliferative leukemia virus oncogene） CD111（英语：PVRL1） CD112（英语：PVRL2） CD113（英语：PVRL3） CD114（英语：Granulocyte colony-stimulating factor receptor） CD115（英语：Colony stimulating factor 1 receptor） CD116（英语：Granulocyte macrophage colony-stimulating factor receptor） CD117（英语：CD117） CD118（英语：Leukemia inhibitory factor receptor） CD119（英语：Interferon gamma receptor 1） CD120（英语：CD120） a（英语：TNFRSF1A） b（英语：TNFRSF1B） CD121 a（英语：Interleukin 1 receptor, type I） b（英语：Interleukin 1 receptor, type II） CD122（英语：IL-2 receptor） CD123（英语：IL3RA） CD124（英语：Interleukin-4 receptor） CD125（英语：Interleukin 5 receptor alpha subunit） CD126（英语：Interleukin-6 receptor） CD127（英语：Interleukin-7 receptor） CD129（英语：Interleukin-9 receptor） CD130（英语：Glycoprotein 130） CD131 CD132 CD133（英语：CD133） CD134（英语：CD134） CD135（英语：CD135） CD136（英语：MST1R） CD137（英语：CD137） CD138（英语：Syndecan 1） CD140b（英语：PDGFRB） CD141（英语：Thrombomodulin） CD142（英语：Tissue factor） CD143 CD144（英语：VE-cadherin） CD146（英语：CD146） CD147（英语：Basigin） CD148（英语：PTPRJ） CD150（英语：SLAMF1）
151-200	CD151（英语：CD151） CD152 CD153（英语：CD153） CD154（英语：CD154） CD155（英语：CD155） CD156 a（英语：ADAM8） b（英语：ADAM17） c（英语：ADAM10） CD157（英语：BST1） CD158 （a（英语：KIR2DL1） d（英语：KIR2DL4） e（英语：KIR3DL1） i（英语：KIR2DS4） k（英语：KIR3DL2）） CD159 a（英语：NKG2） c（英语：KLRC2） CD160（英语：CD160） CD161（英语：KLRB1） CD162（英语：P-selectin glycoprotein ligand-1） CD163（英语：CD163） CD164 CD166（英语：ALCAM） CD167 a b（英语：Discoidin domain-containing receptor 2） CD168（英语：Hyaluronan-mediated motility receptor） CD169（英语：sialoadhesin） CD170（英语：SIGLEC5） CD171（英语：L1 (protein)） CD172 a（英语：Signal-regulatory protein alpha） b（英语：SIRPB1） g（英语：SIRPG） CD174（英语：Fucosyltransferase 3） CD177（英语：CD177） CD178（英语：Fas ligand） CD179 a（英语：VPREB1） b（英语：IGLL1） CD180（英语：CD180） CD181（英语：Interleukin 8 receptor, alpha） CD182（英语：Interleukin 8 receptor, beta） CD183 CD184 CD185 CD186（英语：CXCR6） CD191（英语：CCR1） CD192（英语：CCR2） CD193（英语：CCR3 (gene)） CD194（英语：CCR4） CD195 CD196（英语：C-C chemokine receptor type 6） CD197（英语：C-C chemokine receptor type 7） CDw198（英语：CCR8 (gene)） CDw199（英语：CCR9） CD200（英语：CD200）
201-250	CD201（英语：Endothelial protein C receptor） CD202b（英语：TEK tyrosine kinase） CD204（英语：MSR1） CD205 CD206 CD207（英语：CD207） CD208（英语：LAMP3） CD209（英语：DC-SIGN） CDw210 a（英语：Interleukin 10 receptor, alpha subunitInterleukin 10 receptor, alpha subunit） b（英语：Interleukin 10 receptor, beta subunitInterleukin 10 receptor, beta subunit） CD212（英语：Interleukin 12 receptor, beta 1 subunit） CD213a 1（英语：IL13RA1） 2（英语：IL13RA2） CD217（英语：IL17RA） CD218 （IL18R1a（英语：IL18R1） b（英语：IL18RAP）） CD220（英语：Insulin receptor） CD221 CD222（英语：Insulin-like growth factor 2 receptor） CD223（英语：LAG3） CD224（英语：GGT1） CD225（英语：IFITM1） CD226（英语：CD226） CD227（英语：MUC1） CD228（英语：MFI2） CD229（英语：LY9） CD230 CD233（英语：Band 3） CD234（英语：Duffy antigen system） CD235 a（英语：GYPA） b（英语：GYPB） CD236（英语：Glycophorin C） CD238 CD239（英语：BCAM） CD240CE（英语：RHCE (gene)） CD240D（英语：RHD (gene)） CD241（英语：RHAG） CD243（英语：P-glycoprotein） CD244（英语：CD244） CD246（英语：Anaplastic lymphoma kinase） CD248 CD249
251-300	CD252（英语：OX40L） CD253（英语：TRAIL） CD254 CD256（英语：TNFSF13） CD257（英语：B-cell activating factor） CD258（英语：TNFSF14） CD261（英语：TNFRSF10A） CD262（英语：TNFRSF10B） CD264（英语：TNFRSF10D） CD265（英语：RANK） CD266（英语：TNFRSF12A） CD267（英语：TNFRSF13B） CD268（英语：TNFRSF13C） CD269（英语：TNFRSF17） CD271（英语：Low affinity nerve growth factor receptor） CD272（英语：BTLA） CD273（英语：PDCD1LG2） CD274 CD275（英语：ICOSLG） CD276（英语：CD276） CD278（英语：CD278） CD279（英语：Programmed cell death 1） CD280 CD281 CD282 CD283 CD284 CD286 CD288 CD289 CD290（英语：TLR10） CD292（英语：BMPR1A） CDw293（英语：BMPR1B） CD294（英语：GPR44） CD295（英语：Leptin receptor） CD297（英语：ART4） CD298（英语：ATP1B3） CD299（英语：CLEC4M）
301-350	CD300A（英语：CD300A） CD301（英语：CLEC10A） CD302 CD303（英语：CLEC4C） CD304（英语：Neuropilin） CD305（英语：LAIR1） CD306（英语：LAIR2） CD307（英语：FCRL5） CD309（英语：Kinase insert domain receptor） CD312（英语：EMR2） CD314（英语：NKG2D） CD315（英语：PTGFRN） CD316（英语：IGSF8） CD317（英语：Tetherin） CD318（英语：CDCP1） CD320（英语：CD320） CD321（英语：F11 receptor） CD322（英语：JAM2） CD324（英语：CDH1 (gene)） CD325（英语：CDH2） CD326 CD328（英语：SIGLEC7） CD329（英语：SIGLEC8） CD331（英语：Fibroblast growth factor receptor 1） CD332（英语：Fibroblast growth factor receptor 2） CD333（英语：Fibroblast growth factor receptor 3） CD334（英语：Fibroblast growth factor receptor 4） CD335（英语：NCR1） CD336（英语：NCR2） CD337（英语：NCR3） CD338（英语：ABCG2） CD339（英语：JAG1） CD340 CD344（英语：FZD4） CD349（英语：FZD9） CD350（英语：FZD10）